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ABSTRACT 
All vertebrate species contain a transient ectodermal structure termed the neural 
crest from which a specific subpopulation of migratory cells, the neural crest cells 
(NCCs), is derived. Following an epithelial-mesenchymal transition, NCCs actively 
migrate throughout the developing embryo. Precise temporal and spatial cellular 
migration is essential for the formation of a diverse array of neural crest derived tissues 
and structures. Valproic acid (VP A) is a unique anti-convulsant drug that can produce 
craniofacial and neural tube defects in exposed infants. Alterations of NCC migration, 
proliferation, and cytoskeletal composition have been proposed as mechanisms of VP A's 
teratogenicity. To investigate this drug's effects on NCCs, trunk neural fold explants 
were microdissected from chick embryos and cultured in the presence of0.75- 3.0 mM 
VP A. Computer assisted video image analysis, BrdU proliferation assays, and 
immunostaining with antibodies to F-actin and N-cadherin (A-CAM) were employed to 
investigate NCC behavior during VP A exposure. Overall cell area and width parameters 
were decreased compared to controls for all VP A-treated groups. Perimeter, length, 
elongation index, and migration velocity were not consistently changed from controls. 
Dynamic change in area and dynamic change in perimeter appeared to be negatively 
correlated with VP A concentration. This suggests inhibited cellular motile activity in the 
presence of VP A. VP A exposure increased the number of explants exhibiting a 
continuous epithelial layer of cells extending from the periphery of the attached explants, 
indicating a disturbed ability of the NCCs to complete the epithelial-mesenchymal 
transition necessary for proper migration. Proliferation assays revealed that 2.0 mM VP A 
significantly lowered BrdU incorporation by 11.2% compared to controls. BrdU 
incorporation was inhibited 100% at 3.0 mM VPA. lmmunostaining analysis ofVPA 
exposed explants revealed A-CAM positive cell-cell junctions within attached epithelial 
sheets. Independent NCCs within the same cultures were not positive for A-CAM. This 
suggests VPA altered A-CAM regulation, inhibiting the ability ofNCCs to break free of 
their adherensjunctions. F-actin staining revealed dose-dependant decreases in the 
staining intensity of stress fibers and cortical areas of independent NCCs. In a small 
proportion of2.0 mM VPA exposed NCCs there was an irregular, globular distribution of 
intense (bright) staining not seen in any other concentrations. This pattern was also seen 
in many rounded cells at this concentration. Within explant attached epithelial sheets, 
only cortical areas ofNCCs were stained positively. Stress fiber staining was absent. 
Alteration of neural tube integrity and NCC motile capabilities through increased cell-cell 
adhesion, and lowered or terminated cell proliferation could promote the development of 
NTDs such as spina bifida. Other VP A induced defects might consequently be produced 
through lowered number of NCCs available to contribute to neural crest derivatives. 
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CHAPTER 1 
INTRODUCTION 
Problem 
1 
All vertebrate species contain a transient ectoderrnal structure termed the neural 
crest from which a specific subpopulation of migratory cells, the neural crest cells 
(NCCs), emerges. Individual NCCs are multipotent and have demonstrated limited 
ability to self renew, such as do stem cells (LaBonne and Bronner-Fraser 1998). The 
interaction between the neural tube/plate and the ectodermal epidermis induces formation 
of the NCC population as the apical tips of the neural folds appose. In the cranial 
portions of the tube, detachment of NC Cs begins prior to fusion of the folds, whereas in 
the trunk, they detach after the neural folds have fused. NCCs will migrate into the 
extracellular matrix facilitated by the breakdown of the basal lamina, loss of intercellular 
junctions, loss of neural cell adhesion molecules (CAMs), an increase in fibronectin, and 
an extension of cellular processes (Campbell and others 1986). 
The three subprocesses of neural crest morphogenesis are initiation of migration, 
dispersion of NC Cs away from the neural tube, and termination of migration as cells 
reach their final destination (Erickson and Perris 1993). As the surface ectoderm closes 
above the neural tube, the NCCs emerge from the dorsal portion of the neural tube 
through an epithelial-mesenchymal transition induced by interactions of the neural plate 
and the epidermis. Many specific cell changes within the neural tube have been recorded 
during initiation of migration. These include a reduction in cell-cell adhesion, and 
increase in cell-matrix-adhesion, a general increase in motility correlated with 
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cytoskeletal reorganization and an increase in protease activity. The mechanism and 
regulatory cues coordinating the classic epithelial-mesenchymal transition for NCC 
migration are largely a mystery. The loss or destruction of adhesion proteins involved in 
the junctions may be responsible for this transition. Protein kinase-C inhibitors have 
been demonstrated to have the ability to induce an epithelial-mesenchymal transition 
(Minichiello and others 1999). The basement membrane of the dorsal neural tube is 
discontinuous prior to and during NCC migration initiation, a necessary step for proper 
emigration (Erickson and Perris 1993). Cell adhesion molecules (CAMs) of the cadherin 
superfamily, typically E-cadherin or N-cadherin (A-CAM), are localized principally in 
differentiated adherens junctions (Duband and others 1988). They also can mediate 
adhesion independent of their incorporation into junctions (Gumbiner 2000). The 
adhesion molecules N-CAM, L-CAM and T-cadherin, known to mediate cell-cell 
attachment, are seen in the neural tube. Transmission electron microscopy analysis has 
revealed well-developed adherens junctions at the apical surface of the dorsal neural tube. 
These cadherin-based junctions must be broken before NCC detachment can take place. 
The prominent scenario depicting NCC migration is that of active migration based 
on a balanced environment of promoting and inhibitory signals from a variety of 
molecules within the extracellular matrix. There have been several matrix components 
identified along the dorsolateral side of the neural tube as strong promoters of migration 
including fibronectin, laminin, and collagen types I, Ill, IV, and VI. Focal adhesions (or 
contacts or adhesion plaques) are found on the underside of a migrating cell. They are 
rich in the structural proteins vinculin, paxillin, talin, and a.-actinin, in addition to 
integrins, which are responsible for cell attachment to the matrix. Tyrosine kinases 
including focal adhesion kinase (F AK), c-Src, and c-Csk are also associated with these 
structures and are believed to play critical roles in cell-substrate adhesion and promotion 
of motility (Schaller and others 1992; Bergman and others 1995; Burridge and others 
1992; Ille and others 1995; Kornberg and others 1992; Lipfert and others 1992; 
Richardson and Parsons 1995; Cary and others 1996; Klemke and others 1994). 
The final stage of migration involves the cells reaching their target location and 
ceasing migration. The extracellular signals directing this may be the opposite of those 
responsible for initiation of migration (Erickson and Perris 1993). NCCs contribute to 
facial cartilage, connective tissue, and bone; sensory neurons and glia; Schwann cells; 
brachia!, mandibular, and hyoid arches; melanocytes; smooth muscle; and chromaffin 
(adrenal) cells (Bronner-Fraser 1993). 
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The crawling movements of cells can be broken down into three steps: extension 
of a leading edge, attachment of this edge to the substratum, and retraction of the rear of 
the cell into the cell body. These cell movements are produced by the cytoskeleton, a 
complex cohesive network of filaments and proteins in conjunction with the cortical layer 
of actin filaments associated with a diverse collection of actin-binding proteins. 
Crawling cells have a leading lamella, a flat anterior end, and narrow tail, creating an 
observable polarity. The term "cortical flow" encompasses movements of the lamellar 
substance. A dynamic cycle of actin assembly and disassembly operates throughout the 
entire lamella. This complex internal scaffolding is useless without the accessory 
proteins that link the filaments to each other and to other parts of the cell. They 
strengthen the cytoskeleton by crosslinking and forming bundles within it, and allow 
generation of internal movements of organelles using the filaments like tracks. 
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All pregnancies carry a three percent risk for a major birth defect independent of 
any intrinsic or extrinsic factors (Buehler and others 1994). Neural tube defects (NTDs) 
are malformations affecting the brain and/or spinal cord that may or may not result from 
abnormal neural tube closure (DeSesso and others 1999). Spina bifida and anencephaly 
account for 50% and 40%, respectively, ofNTD cases (Lewis and others 1998). Spina 
bifida includes all abnormalities in which vertebral arches fail to close dorsal to the spinal 
cord to form the vertebral canal, and may or may not involve the spinal cord itself. There 
are several types of spina bifida ranging from no impairment to severe impairment. 
The etiology ofNTDs is multifactorial. Fetal drug exposure is one of many 
important factors in NTD development. At least 221 teratogenic agents have been 
associated with the production of NTDs in at least one species (De Sesso and others 
1999). Valproic acid (VPA), a weak human teratogen, is a simple eight carbon, 
branched-chain fatty acid. It is mainly indicated as prevention or cure for myoclonic 
seizures, partial seizures, status epilepticus, and tonic-clonic seizures, mania, and 
migraine (Browne 1980). The exact mechanism ofVPA's beneficial effects as well as 
it's teratogenic potential is poorly understood. Multiple reports since 1976 have shown 
VP A to be a potent teratogen in the rabbit, mouse, rat, hamster, axolotl, and chick. The 
most common NTD seen in human infants exposed to VP A is spina bifida. Spina bifida 
has been shown to result from lowered cellular proliferation in the neuroepithelium. 
Numerous studies have demonstrated that when it is altered, NTDs can result (Copp 
1988, 1990; Bennett and others 2000). 
Matrix and cell adhesion molecules, when disturbed at the time of neurulation, 
can also be involved in the generation of NTDs by altering cell adhesion dependant 
morphogenic events (Newgreen and others 1997). When the extracellular matrix 
molecules laminin, fibronectin, and chondroitin sulfate proteoglycan and the cell 
adhesion molecules E- and N- cadherin, and N-CAM were examined in quail embryos 
with spontaneous NTDs, it was determined that these molecules are disturbed in 
spontaneous NTDs during neurulation (Newgreen and others 1997). 
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Several hypotheses are being investigated to identify the mechanism(s) ofVPA's 
teratogenicity. These hypotheses include interference with embryonic lipid metabolism, 
interference with zinc metabolism, and interference with neurotransmitter metabolism 
(Clarke and Brown 1987; Wegner and others; Nau 1994). Another hypothesis examines 
alteration of intracellular pH, which is an important parameter of numerous cellular 
functions and seems to be a promising area of study because the early mammalian 
embryo has a relatively high intracellular pH and may then accumulate acidic compounds 
such as VPA via ion trapping (Scott and others 1990 cited in Nau 1994). Lastly, 
interference with embryonic folate metabolism is currently being investigated (Nau 
1994). 
VP A has been shown to inhibit the proliferation of neuronal cells in culture and 
recent studies have been carried out to determine the explanation. Transcriptional 
activities of genes coding for several growth factors, receptors and neurotrophic factors 
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was investigated by Bennett and associates (2000). They used two VP A sensitive strains 
of mice, LM/Bc (less) and SWV (more), and found that transcriptional activity of 
neurotrophic and growth factor genes were altered during neurulation in the presence of 
VPA. 
VP A and VP A-analogues have been demonstrated to increase mean cell area of 
cultured fibroblastoid L-cells in correlation with the teratogenic potential of each 
analogue tested (Berezin and others 1996). Walmod and others (1999) demonstrated that 
after treating L929 cells with 3mM there was increased flattening and spreading of the 
cells compared to control. Overall, the cells were larger and had more and/or longer 
processes. Relative F-actin per cell was calculated and found to be significantly higher 
(23%) for treated cells. F-actin distribution was altered indicated by an increase amount 
of stress fibers, and a decrease in cortical F-actin and lower numbers of membrane 
ruffles. VP A treatment induced an increase of phosphotyrosine, paxillin, vinculin, and 
focal adhesion kinase (F AK). This supports the hypothesis that VP A might cause a 
decrease in cell motility through increased cell-substratum adhesion (Walmod and others 
1999). Walmod and others (1998) performed experiments on fibroblastoid L-cells in 3.0 
mM VP A, and found that cellular migration was inhibited in a dose dependant manner. 
Confocal micro graphs of fluorescence staining of microtubules, F-actin, and selected 
focal adhesion proteins demonstrated that VPA-exposure caused an enhanced focal 
adhesion formation accompanied by a rearrangement of F-actin reflected by an increase 
in stress fiber formation (Walmod and others 1998). In addition, treated cells seemed to 
be devoid of microspikes, which were observed in great numbers in control cells. 
Objectives 
Left and right neural folds will be dissected from chick embryos ofHamburger-
Hamilton stages 10- - 1 o+ (Hamburger and Hamilton 1951 ). One fold will be cultured as 
a control. The other will be cultured in the presence of0.75, 1.5, 2.0, or 3.0 mM VPA. 
The neural fold explants and migratory NCCs will be analyzed after 24 hours of culture. 
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The objectives of this study were: (1) to assess the effect ofVPA on overall 
morphology in culture of both the neural fold explants and associated migratory NCCs 
using computer-assisted video image analysis; (2) to evaluate VPA's effect on motile 
behavior of the cultured migrating NCCs using computer-assisted video image analysis; 
(3) to determine VPA's effect on the proliferation rate ofNCCs; and (4) to reveal the 
effect ofVPA on the cellular distribution ofN-cadherin (A-CAM), and filamentous actin 
in both control and drug-treated groups. 
Literature Review 
Neural Crest Cells 
Towards the end of gastrulation there are three layers of cells, the ectoderm, 
endoderm, and mesoderm. Each layer gives rise to specific structures in the developed 
embryo. The entire nervous system and the epidermis are derived from the ectoderm 
(Bronner-Fraser 1998). All vertebrate species contain a transient ectodermal structure 
termed the neural crest from which a specific subpopulation of migratory cells, the neural 
crest cells (NCCs), emerges. Traditionally, NCCs have been thought of as a segregated 
population of cells within the neural plate, bordered by presumptive epidermis and 
central nervous system. Recent cell lineage analyses, however, have indicated a common 
origin within the neural folds for epidermal, neural crest and neural tube derivatives. 
Individual NCCs are multipotent and have demonstrated limited ability to self renew, 
such as do stem cells (LaBonne and Bronner-Fraser 1998). 
In the chick, neurulation comprises several phases and has distinct patterns. 
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During neural induction, the medial ectoderm thickens and then invaginates into a neural 
groove. The paired crests of the neural groove rise and come into contact initially in the 
head region at several different locations. The first closure site is in the future 
mesencephelon at approximately 30 hours post incubation at Hamburger-Hamilton stage 
8 (Hamburger and Hamilton 1951 ). Within 4 hours, a second closure site is seen at the 
rhombocervical level in the form of multisite contacts of the neural folds. The folds 
continue to meet and close caudally in a zipperlike manner as the apical tips of the neural 
folds appose and numerous contact points are made. The folds fuse mainly in a posterior 
direction to form a complete tube open at both ends that separates from the adjacent 
ectoderm. 
The interaction between the neural tube/plate and the ectodermal epidermis 
induces formation of the NCC population as the apical tips of the neural folds appose. 
Evidence points to the proteins dorsalin-1, BMP-4 and BMP-7, all members of the 
transforming growth factor p superfamily, to be involved with this interaction (Basler and 
others 1993; Liem and others 1995). These proteins are expressed in the epidermal 
ectoderm at the time of neural crest induction in the chick and are sufficient to substitute 
for the non-neural ectoderm in inducing NCCs in vitro (Liem and others 1995). When 
BMP4 and BMP7 activity is blocked, the epidermal ectoderm is unable to induce NCCs 
(Liem and others 1997). 
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In the cranial portions of the tube, detachment of NC Cs begins prior to fusion of 
the folds, whereas in the trunk, they detach after the neural folds have fused. NCCs 
migrate into the extracellular matrix facilitated by the breakdown of the basal lamina, loss 
of intercellular junctions, loss of neural cell adhesion molecules ( CAMs ), an increase in 
fibronectin, and an extension of cellular processes (Campbell and others 1986). Within 
the neural folds, individual precursor cells have the potential to contribute to the 
epidermal, neural tube, or neural crest lineages. Currently it is not understood exactly 
what causes only specific cells to leave, or when during their migration these cells 
become committed to a certain fate. Timing of emigration appears to restrict the range of 
possible NCC derivatives (Serbedzija and others 1994). 
Cranial derived NCCs of the caudal forebrain populate the cardiac ganglion and 
the enteric ganglia of the gut. Those of the midbrain contribute to most of the facial 
cartilage and bone, facial connective tissues, ciliary and trigeminal ganglion, and 
Schwann cells. Hindbrain NCCs migrate to form the mandibular and hyoid arches, 
genticulate and vestibular ganglia, brachia! arches, peripheral ganglia, cardiac ganglia, 
enteric ganglia, melanocytes, and chromaffin (adrenal) cells. Trunk derived NCCs form 
melanocytes, sensory neurons and glia, sympathoadrenal cells, smooth muscle, and 
Schwann cells (Bronner-Fraser 1993). 
There are two models to explain the considerable differences in the fates of these 
seemingly identical cells. The environment-directed model maintains that most NCCs 
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are multipotent when they leave the neural tube, and the timing of their departure 
depends on the environmental cues encountered at dispersion. Differentiation occurs as 
exposure to local environmental cues changes along each particular path. In a number of 
studies, single avian NCCs have been isolated and allowed to proliferate into a colony of 
clones in the presence of differing growth factors. Melanocytes, sympathetic neuroblasts, 
and sensory neurons were all observed in the different cultures. Similar in vitro studies 
with rat and mouse NCCs resulted in a trio of differing cell types for each respective 
experiment (Stemple and others 1992; Ito and others 1993; and Shah and others 1996) 
supporting the environment-directed model. 
In the phenotype-directed model, NCCs are specified as a particular lineage 
around the time of emigration from the neural tube. This specification results in 
molecular changes in NCC subpopulations, thus directing the specific migratory path to 
be taken. There is much less evidence for this type of specification (Bronner-Fraser 
1995; Erickson and Reedy 1998). 
It has also been suggested that escape from the neural tube may be responsible for 
the separation of the NCC lineage. Fate-mapping studies have demonstrated that large 
numbers of NC Cs must be destroyed to effect the final derived structures. Ablation of a 
small portion of the mesencephalic, occipital, or cervical dorsal neural tube does not 
result in an abnormal embryo (Bronner-Fraser 1995). Ablation of cardiac NCCs 
frequently generates abnormal heart, great vessel, and parasympathetic nerve 
development. Following ablation ofNCCs, replacement cells migrate into the gap from 
both anterior and posterior positions. Increased cell division or decreased cell death near 
the extirpation site may also contribute to cell replacement, but evidence is currently 
lacking (V aglia and Hall 1999). It is clear that in a normal embryo, the region that 
actually becomes neural crest is only a portion of the overall potential region (Bronner-
Fraser 1995; Selleck and Bronner-Fraser 1996). 
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Because migrating NCCs are morphologically indistinguishable from other 
embryonic cell types, specific markers had to be developed in order to study them. 
HNK-1 (NC-1) antibody has been very effective, especially in avian studies. It does not 
appear to label mouse or amphibian NCCs however. Lipophilic fluorescent dyes have 
been used to inject both single cells and cohorts of presumptive NCCs with excellent 
results (Selleck and Bronner-Fraser 1996). Because NCC migration routes are so 
intimately linked to the cell's final fate, it is essential to understand pathway 
establishment and guidance mechanisms underlying their migration. 
Morphogenesis of the Neural Crest 
The three subprocesses of neural crest morphogenesis are initiation of migration, 
dispersion ofNCCs away from the neural tube, and termination of migration as cells 
reach their final destination. Continuous cell-cell and cell-matrix interactions are known 
to govern each particular step of morphogenesis, but the specific mechanisms involved in 
NCC detachment from the neural epithelium as well as the onset of migration are poorly 
understood (Erickson and Perris 1993). As the surface ectoderm closes above the neural 
tube, the NCCs emerge from the dorsal portion at the region of the most newly formed 
somite through an epithelial-mesenchymal transition induced by interactions of the neural 
plate and the epidermis. The ability of the neural plate to respond to inductive cues 
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appears to depend on the age of the embryo. NCCs emerge in a wave that begins in the 
anterior of the embryo and proceeds posteriorly. A number of factors have been 
proposed to be critical at this step including: (1) basement membrane disruption 
permitting NCC escape; (2) deposition of suitable migratory substratum for NCC 
migration along the dorsal neural tube; (3) acquisition of motile capabilities; and (4) loss 
of high affinity cell-cell adhesions with an increase in cell-matrix adhesion. The 
molecular event(s) that are responsible for triggering initial emigration is still largely a 
mystery, but many specific cell changes within the neural tube have been recorded. 
These include a reduction in cell-cell adhesion, and increase in cell-matrix-adhesion, a 
general increase in motility correlated with cytoskeletal reorganization and an increase in 
protease activity (Erickson and Perris 1993). 
The basement membrane of the dorsal neural tube is discontinuous prior to and 
during NCC migration initiation. It is continuous in the remaining portions where NCCs 
are not seen. Before the fusion of the neural folds, one of the first morphogenic events 
seen during head NCC migration is disruption of the neural epithelial basement 
membrane that envelops them. In addition, early migrating NCCs seem unable to 
penetrate intact basement membranes in vivo or when challenged in culture with a 
placental membrane. Taken together, this supports the idea that lack of intact basement 
membrane is a necessary step for proper emigration (Erickson and Perris 1993). 
NCCs are recognizable as a separate population once they have emerged from the 
neural tube. The mechanism and regulatory cues coordinating this classic epithelial-
mesenchymal transition for NCC migration are largely a mystery. One theory implies 
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that NCCs are able to generate enough tractional force (based on increased NCC affinity 
for fibronectin and laminin just prior to migration) to simply pull away from the adherens 
junctions anchoring them to the luminal surface. NCCs are known to produce a number 
of proteases and their production increases about the time of emigration. 
Another theory states that the loss or destruction of adhesion proteins involved in 
the junctions is responsible for the transition. In all solid tissues, cadherins are major 
cell-cell adhesion molecules involved in development and maintenance. Cadherins form 
tight complexes with catenins, believed to link the cadherins functionally to the actin 
cytoskeleton. Cell adhesion molecules (CAMs) of the cadherin superfamily, typically E-
cadherin or N-cadherin (A-CAM), are localized principally in differentiated adherens 
junctions (Duband and others 1988). They also can mediate adhesion independent of 
their incorporation into junctions (Gumbiner 2000). Transmission electron microscopy 
analysis has revealed well-developed adherens junctions at the apical surface of the 
dorsal neural tube. The adhesion molecules N-CAM, L-CAM and T-cadherin, known to 
mediate cell-cell attachment, are also seen in the neural tube. These cadherin-based 
junctions must be broken before NCC detachment can take place. In some studies, lower 
levels of A-CAM have been seen in the dorsal neural tube just prior to NCC migration. 
There is other evidence, however, that supports the loss of function of A-CAM instead. It 
has been suggested that the state of phosphorylation of junctional proteins regulates A-
CAM function by adjusting cadherin connection to the cytoskeleton of the NCCs 
(Erickson and Perris 1993; Selleck and Bronner-Fraser 1996; Erickson and Reedy 1998). 
It has been discovered that A-CAM and E-cadherin both are lost from the NCCs prior to 
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or shortly after detachment from the neural tube as they initiate migration. In mice with 
abnormally high levels ofN-CAM, NCCs fail to migrate from segments of the neural 
tube, and the resulting embryos display spina bifida (Moase and Trasler 1990, 1991). It 
is known that chick NCCs also downregulate cadherin-B6 and upregulate cadherin-7 
while losing their neuroepithelial morphology (Akitaya and Bronner-Fraser 1992; 
Nakagawa and Takeichi 1995). 
Protein kinase-C inhibitors can also induce epithelial-mesenchymal transitions. 
Conventional, novel and atypical isoforms of protein kinase-C are found in embryonic 
neural tissues. Immunolocalization has shown atypical isoforms enriched at the apical 
margin of the neural epithelia, overlapping with A-CAM and F-actin. Because atypical 
protein kinase-C isoforms are present at the appropriate developmental stage and 
subcellular site, they may contribute to the epithelio-mesenchymal transition of neural 
cells (Minichiello and others 1999). 
A-CAM's role as an adhesion molecule is also involved in the establishment of 
embryonic asymmetry. It is one of the earliest proteins to be asymmetrically expressed in 
the chick embryo. For proper establishment of the left-right axis, it must be expressed 
during gastrulation. Blocking A-CAM function randomizes heart looping and alters the 
expression of later components of the molecular cascade resulting in left-right asymmetry 
(Garcia-Castro and others 2000). 
Bone morphogenic protein (BMP) family members are strong candidates for 
specification of NCC fate (Shah and others 1996). Identification of genes induced by 
bone morphogenic proteins (BMPs) might help elucidate the mechanism of induction. In 
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chick, the zinc finger transcription factor slug is expressed in both the dorsal folds of the 
neural plate and neural tube, and later in migrating NCCs (Liem and others 1995). A 
reorganization of the cytoskeleton, and cell surface adhesion molecules and receptors 
accompanies the onset of NCC migration. Little is known about the extent of regulation 
of expression of cell surface proteins by BMP signaling. In a screen for molecules 
participating in early steps of NCC differentiation via BMP induction, rhoB was 
identified. This molecule is a member of the rho gene family, which code for small GTP-
binding proteins of the ras superfamily. The three major members of this family, rho, 
rac, and cdc42 appear to be involved in adhesion, morphology, motility, and cell cycle 
progression (Hall 1998; Van Aelst and D'Souza-Schorey 1997). RhoB is expressed 
selectively by cells in the dorsal neural tube upon induction by BMPs. It also is 
transiently expressed in migrating NCCs. They are prevented from delamination of the 
dorsal neural epithelium when rho activity is blocked by C3 endotoxin, suggesting a role 
for rhoB in this step. NCCs have a more elongated morphology overall when rho activity 
is blocked, but no significant changes are noted in migration (Liu and Jessell 1998). 
NCC emigration does not appear to be triggered by the main extracellular matrix 
molecules present in migratory pathways. Premigratory NCCs have reduced adhesion 
and locomotion capabilities on ECM molecules compared to migratory crest cells. 
During the transition from premigratory to migratory, NCCs gradually acquire the ability 
to adhere to substratum. Extracellular matrix molecules failed to induce premature 
migration from premigratory NCCs, therefore a soluble factor may be present in the 
extracellular environment that may induce emigration. Transforming growth factor p is a 
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leading candidate. It is expressed early during embryogenesis, it's involved in a variety 
of morphogenic processes, and it regulates integrin expression. Delannet and Duband 
(1992) found that transforming growth factor Bis able to induce premature emigration 
from the neural tube and enhance fibronectin adhesion of NC Cs in vitro. It does not, 
however, seem to affect the cell-cell adhesion, proliferation, or locomotory behavior of 
NCCs. Potentially it may modify either the expression pattern or binding specificities of 
integrins on the surface of these cells (Delannet and Duband 1992). 
Once out of the tube, all NCCs are morphologically similar, but migrate along 
distinct pathways and differentiate into a variety of cell types. In general, active NCCs 
appear to migrate without the guidance of long-range chemical or physical cues, using 
instead the heterogeneity of the extracellular matrix substratum (Henderson and Copp 
1997). The prominent scenario depicting NCC migration is that of active migration 
based on a balanced environment of promoting and inhibitory signals from a variety of 
molecules within the extracellular matrix. There have been several matrix components 
identified along the dorsolateral side of the neural tube as strong promoters of migration 
including fibronectin, laminin, and collagen types I, III, IV, and VI. Functional cell-
matrix receptors on the cell surface are also required to interact with the matrix, and 
appropriate cell markers are needed to mediate attachment. Integrins comprise a family 
of cell surface heterodimeric glycoproteins capable of binding both matrix molecules and 
cell surface receptors. Recruitment of integrins by their ligands induces the formation of 
focal adhesion sites where complex signaling machinery is established between integrin 
clusters and the cytoskeleton. NCCs express a minimum of eleven distinct heterodimers 
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of integrin. At least five al and three p 1 integrins are implicated in the interaction of 
NCCs with fibronectin and laminin (Henderson and Copp 1997). Not all integrins 
expressed are involved in adhesion and migration however; they may have additional 
functions relating to cell proliferation, survival, and differentiation. Such a diversity of 
receptors is believed to allow migrating cells to adapt to multiple changes of environment 
as they populate various areas of the embryo (Testaz and others 1999). Laminin, a major 
component of basal laminae, functions in NCC adhesion, migration and differentiation. 
Receptors for laminin include at least nine members of the integrin family. In NCCs, the 
a, 1 p 1 member binds a unique fragment of laminin compared to other cell types, and this 
may be responsible for some of the differing adhesive responses for the different cell 
types (Desban and Duband 1997). Other matrix receptors may be involved in the onset 
and early NCC migration, but data is limited due to lack of immunological and molecular 
probes for avian receptors (Erickson and Perris 1993). 
Focal adhesions ( or contacts or adhesion plaques) are found on the underside of a 
migrating cell. They are patches of the cell membrane that interact with the extracellular 
matrix, remaining in a fixed position on the substratum while the cell passes over. If a 
cell is rapidly displaced such as with a blast of fluid, the focal adhesions are left behind, 
indicating they were anchored to the substratum. They are rich in the structural proteins 
vinculin, paxillin, talin, and a,-actinin, in addition to integrins. Integrins are found 
embedded in the plasma membrane with a site for fibronectin attachment on the exterior 
of the cell, and site for talin attachment inside. Talin is then connected to vinculin, which 
is associated with a,-actinin and cortical actin filaments of the cytoskeleton (Bray 1992). 
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Tyrosine kinases including focal adhesion kinase (F AK), c-Src, and c-Csk are also 
associated with these structures and are believed to play critical roles in cell-substrate 
adhesion and promotion of motility (Schaller and others 1992; Bergman and others 1995; 
Burridge and others 1992; Ille and others 1995; Kornberg and others 1992; Lipfert and 
others 1992; Richardson and Parsons 1995; Cary and others1996; Klemke and others 
1994). 
The receptors for epidermal growth factor and hepatocyte growth factor, soluble 
factors that can induce epithelial-to-mesenchymal transition (EMT) are protein tyrosine 
kinases (PTKs) (Komada and Kitamura 1993). Tyrosine kinase inhibitors have been 
shown to elevate cadherin levels at cell adhesions and increase NCC-cell adhesion 
(Monier-Gavelle and Duband 1995). Because NCCs can be influenced by protein 
tyrosine kinase-derived signals (also see below), it is reasonable to hypothesize that 
protein tyrosine phosphatases (PTPases) co-regulate these events via phosphotyrosine 
signals. Numerous cytoplasmic and transmembrane PTPase genes have been identified 
and have been found to be receptor-like molecules structurally related to cell adhesion 
molecules (CAMs). Scant information is available concerning the potential cooperative 
influences of PTPases and PTKs over NCC motility. Brennan and others (1999) however 
have demonstrated that the activities of these molecules are both required for the 
maintenance of NCC motility on culture. PTPases contribute to NCC locomotion by 
influencing cell-cell adhesion and focal adhesion dynamics. If PTPases are inhibited 
with vanadate or herbimycin-A, NCCs migrating on fibronectin show a significant dose-
dependant decrease in migration rate as well as layering pattern changes. Instead of 
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forming a haphazard layer of overlapping cells with a leading edge of freely migrating 
cells, NCCs migrated as a compact cohesive sheet with few separated cells. Within this 
sheet, the extensive borders between cells were cadherin-rich; A-CAM represented at 
least some of this cadherin population. In contrast, the addition of a different inhibitor, 
genistein, showed no enhancement of cadherin concentration in cell-cell borders. Using 
PTK inhibitors, PTPase and PTK-dependant signaling pathways were demonstrated to 
cooperate to promote NCC migration on fibronectin. PTKs also are a prerequisite for 
focal adhesion formation. Without herbimycin A-sensitive PTK activity, focal adhesions 
largely fail to form. PTPase inhibition induces large aberrant aggregates of focal 
adhesion proteins, suggesting a key role for PTPases in focal adhesion distribution. 
There is also a novel function for genistein-sensitive PTKs in abrogating a contact-
mediated inhibition of movement, which is latent in these cells. Overall, the maintenance 
of cell migration is controlled in at least three ways by PTPases and PTKs: (1) 
upregulation of expression or enzyme activity of particular PTPases and PTKs; (2) 
maintenance of low cell-cell adhesion and dynamic substrate adhesion by these enzymes; 
and (3) abrogation oflatent contact-mediated inhibition (Brennan and others 1999). 
At Hamburger Hamilton stage 12-13, the first of two waves of migration find 
NCCs migrating ventrally between the neural tube and somites. Interestingly, NCCs 
invade only the anterior portion of the somites and tend to stay in a dorsal position. As 
NCCs are precursors to ganglia, this patterned distribution results in the segmental 
organization seen in sensory and sympathetic ganglia later. Several inhibitory molecules 
have been found in the posterior halves of somites, but until recently molecules 
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promoting cellular migration into the anterior portion of the somite had not been 
discovered. Tucker and others (1999) have recently identified that thrombospondin-1, 
originally identified as a protein secreted from platelets, may promote the migration of 
NCCs through the anterior portion of the somites. It was immunolocalized to the 
extracellular matrix where NCCs migrate in early development (Tucker and others 1999). 
Many of these early NCCs are pluripotent, having the ability to generate progeny of more 
than one cell type. The sensory and sympathetic ganglia, glial cells and portions of the 
adrenal medulla are a few of the final structures to which these early NCCs contribute. 
Evidence suggests that environmental factors and not predisposition are 
responsible for directing this early wave of NCCs. Neurotrophins, stem cell factor, and 
other growth factors have been demonstrated to affect NCC proliferation, survival, and 
differentiation in several lineages. Stem cell factor is a survival factor for pluipotent 
NCCs, and promotes differentiation ofNCCs into cells of the sensory neuron lineage. 
Transforming growth factor Pl is a mitogen inducing neurotrophin dependency, and is a 
powerful anti-mitotic signal for all NCCs. Neurotrophin-3 specifically promotes high 
affinity uptake of norepinephrine, potentially playing a role in the differentiation of 
sympathetic neuroblasts. Various combinations of these growth factors also have specific 
effects differing from the action of each as an individual. Pluripotent NCCs have been 
found even at sites of terminal differentiation, further supporting the idea that cues 
originating from the microenvironment, at least in part, direct NCC type specification 
(Sieber-Blum and Zhang 1997). 
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Twenty-four hours later in the second migration wave, NCCs invade the 
dorsolateral space between the somites and ectoderm. Melanocytes are the only NCC 
derivatives found exclusively along this path. The cells travel uniformly across the top of 
the somite, unlike earlier cells. These presumptive melanocytes enter the epidermis 
where basement membrane is disrupted within 24 hours after invading the dorsolateral 
path. A possible explanation for the exclusivity of melanoblasts to this pathway may be 
that they need to differentiate from the rest of the NCC population by acquiring the 
ability to overcome inhibitory molecules found along this specific path. This may be 
accomplished through the loss of receptors for the inhibitor cues. Alternatively, they may 
be the only subpopulation sensitive to unknown positive migration cues. Overall, early 
evidence suggests that the migration of these potential pigment cells is made possible by 
gaining the ability to exploit an inhibitory matrix coincident with overall changes in the 
matrix composition (Erickson and Perris 1993; Erickson and Reedy 1998). 
Evidence is emerging of various embryonic tissues acting as barriers to NCC 
migration, such as the caudal part of the sclerotome, the dermomyotome, and the 
perinotochordal mesenchyme. In areas where NCCs do not migrate, several molecules 
have been discovered that inhibit NCC migration such as collagen IX, chondroitin sulfate 
proteoglycans, and the peanut-agglutinin (PNA)-binding molecules aggrecan and 
versican (Ring and others 1996; Landolt and others 1995; Henderson and others 1997; 
Perris and others 1991; and Kerr and Newgreen 1997). Aggrecan, strongly inhibitory to 
avian NCC migration, is thought to be responsible for the repulsive effects of the 
notochord (Perris and others 1996). Versican, less inhibitory than aggrecan, is expressed 
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in the caudal sclerotome and notochord as well. When it is over expressed along NCC 
migration pathways, as in murine splotch mutants, a variety of developmental defects are 
observed, including deficiency of NCC derivatives and spina bifida (Landolt and others 
1995). Mutations in the endothelin-B receptor cause an overabundance of laminins, 
collagen type IV, and proteoglycans, resulting in abnormalities of pigmentation and 
absent or diminished innervation of the gut (Baynash and others 1994; Tennyson and 
others 1990). 
Members of the Eph family of receptor tyrosine kinases (RTK.s) and their ligands, 
the ephrins, appear to play an inhibitory role in directing segmental migratory pathways 
in both the trunk and hindbrain regions. EphB RTKs and ephrin-Bl are expressed in 
striking non-overlapping patterns during trunk neural crest migration. It turns out that 
ephrin-B 1 affects NCCs directly by inducing a typical avoidance response, conferring the 
rostrocaudal polarity to trunk neural crest migration (Krull 1998). In neurites, the 
interaction of the chondroitin sulfate proteoglycan neurocan with its receptor coordinately 
inhibits both A-CAM and ~1-integrin-mediated adhesion and neurite outgrowth. This 
may prevent cell and neurite migration across specific boundaries within the embryo 
(Leung and others 2000). Collapsin-1, belonging to the Semaphorin family of molecules, 
is expressed within the somites and the cranial neural tube along the borders of NCC 
migratory pathways coincident with the onset of NCC migration. Neurophilin-1, an 
essential part of a neuronal receptor complex for collapsin-1, is expressed in migrating 
NCCs. In vitro assays have shown explanted NCC avoidance of substratum areas 
containing collapsin-Fc, suggesting a role for this molecule in migration route patterning 
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(Eickholt and others 1999). F-Spondin is also expressed in somite areas that NCCs avoid 
during migration (Debby-Brafman and others 1999). 
The final stage of migration involves the cells finding their target location and 
ceasing migration. The extracellular signals directing this may be the opposite of those 
responsible for initiation of migration. Around the dorsal root ganglia, for example, a 
basement membrane containing the characteristic components laminin, collagen type IV 
and VI, and perlecan appear soon after the coalescence of the NCCs. 
Chondroitin/keratan sulfate proteoglycans and decorin, linking matrix molecules 
inhibitory for NCC movement, are found intimately associated with subepidermal 
basement membrane potentially connecting it to the interstitial matrix. The 
overabundance of these typical matrix components and their macromolecular 
arrangement in the matrix surrounding NCCs may transform the substratum into one that 
inhibits migration. Changes are also seen in the surface components possibly responsible 
for the cell's interaction with the matrix. The down regulation of hyaluronan, which 
interferes with cell-cell adhesion, also occurs potentially increasing the stability of the 
cell in its final location. Finally, reexpression of adhesion molecules such as N-CAM, A-
CAM, and E-cadherin suggest increased cell-cell affinity (Erickson and Perris 1993). 
The control of A-CAM may rely directly on the activity of integrins involved in the 
process of cell motion. As NCCs end migration aggregating into peripheral ganglia, A-
CAM is reexpressed on their surfaces coincidentally with the disappearance of 
fibronectin. In in vivo studies, an inverse correlation between the expression of A-CAM 
and the migratory behavior of NC Cs has been established. This suggests a precisely 
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regulated negative control system for the expression and function of A-CAM molecules 
during migration. Consistently, in vitro NCCs do not establish extensive intercellular 
contacts during migration despite having A-CAM molecules on their surfaces. In these 
cells, A-CAM is excluded from regions of cell-cell contact. When serine-threonine 
kinases, tyrosine kinases, and phosphotyrosine phosphatases are inhibited, aggregates of 
cells form with tight cell-cell cohesion among cells accompanied by A-CAM 
accumulation in the areas of intercellular contacts. This indicates a complex cascade of 
intracellular signals involving kinases and phosphatases elicited by surface receptors as a 
mechanism of A-CAM mediated interactions. The receptors that would regulate these A-
CAM junctions are not yet known. Because integrins constitute major receptors for 
extracellular matrix molecules involved in NCC migration, a question is raised related to 
whether or not they might be a part of the regulatory mechanism of A-CAM activity. 
Agents that interfere with fibronectin-to-integrin interactions cause rapid A-CAM-
mediated cell-cell aggregations. This process is mediated by A-CAM molecules being 
incorporated from cytoplasmic pools into adherens junctions that are associated with 
cytoskeletal elements (Monier-Gavelle and Duband 1997). 
Cell Motility 
The crawling movements of cells can be broken down into three steps: extension 
of a leading edge, attachment of this edge to the substratum, and retraction of the rear of 
the cell into the cell body. These cell movements are produced by the cytoskeleton, a 
complex cohesive network of filaments and proteins in conjunction with the cortical layer 
of actin filaments associated with a diverse collection of actin-binding proteins. Three 
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principle protein filaments make up the cell's internal scaffolding. Microtubules are the 
largest at 25 nm diameter, and are constructed oftubulin heterodimers. They are found 
forming a polarized lattice throughout the cytoplasm. Focal complex dynamics 
responsible for formation, maintenance, and removal of focal adhesions are in part 
regulated by microtubules. Depolymerization ofmicrotubules in fibroblasts leads to a 
decrease in the turnover of focal complexes, resulting in reduced cell spreading, large 
peripheral focal adhesions, and reduced protrusive activity. Adhesions dissociate upon 
direct contact with microtubules, and either the cell retracts or a new protrusion forms. 
These relaxing signals are likely regulated by members of the Rho family, but the exact 
nature of the signals is unclear. Migratory defects that manifest as inhibited focal 
adhesion turnover have been reported in cells lacking the focal adhesion components 
calpain, focal adhesion kinase, and SRC family kinases (Klinghoffer and others 1999; 
Sieg and others 1999; Huttenlocher and others 1997). These cells show inhibited cell 
spreading and strong focal adhesions predominately at the cell periphery perhaps due to 
an inability to recycle adhesive components (Horwitz and Parsons 1999). 
Intermediate filaments have a distribution similar to microtubules, but have a 
smaller diameter of 10 nm. They are made of a unique family of proteins often 
distinctive of a particular cell type, such as keratin in epithelial cells, desmin in muscle 
cells, or vimentin in fibroblastoid cells (Bray 1992). 
Actin filaments are the smallest type (eight nm diameter) and are composed of the 
protein actin. Cortical actin filaments interact with a diverse array of actin-binding 
proteins to produce movement. Cell process extension, anchorage, and contraction is 
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facilitated by actin polymerization and depolymerization. The actin network is stabilized 
through the formation of adhesion complexes or focal adhesions. Integrin receptors, actin 
filaments, and associated proteins gather within the plasma membrane in these regions. 
Cooperation of actin filaments, cross-linking proteins such as a-actinin, actin 
fragmenting proteins such as gelsolin, and various forms of myosin are responsible for 
motile behavior. As the cells migrate, focal complexes (small nascent adhesion 
complexes) at the front grow and strengthen into more organized focal adhesions that 
serve as points of traction over which the body of the cell moves. In stationary 
fibroblasts, it has been discovered that these adhesions are highly motile, while in 
migrating cells they are stationary, suggesting the existence of a molecular clutch 
coupling traction and contractile forces. The mechanism that regulates formation and 
release of these complexes remains unclear (Horwitz and Parsons 1999). Surface 
stimulation by various soluble or substrate-bound proteins, peptides, lipids and small 
molecules initiates crawling behavior. 
Crawling cells have a leading lamella, flat anterior end, and narrow tail, creating 
an observable polarity. Multiple organelle free lamellae are produced, but only those that 
contact the surface in focal contacts are capable of generating locomotion. Typically, an 
actively crawling cell will have one dominant lamella, and others retract coordinately. 
Cell type and external environment affect lamellar advancement. Forming extensions of 
the leading lamella are cylindrical spikes called filopodia, or expansions of small blebs 
that flatten and cluster. Ruffling is also seen, where the leading edge of the lamellar veil 
lifts upward from the substrate and bends backward perpendicular to the adherent portion 
of the lamella. This ruffle then migrates rearward toward the cell body while retracting 
and dissipating over it. 
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The term "cortical flow" encompasses movements of the lamellar substance. The 
leading lamella is elastic, and is stiff enough to deform or push objects out of its way 
(Stossel 1993). The association between actin polymerization and membrane protrusion 
had been well established, but the actual driving force for membrane extension of the 
leading lamellae is unclear. A dynamic cycle of actin assembly and disassembly operates 
throughout the entire lamella. Actin has intrinsic self-association properties resulting in 
polarized filaments. Supporting these filaments are regulatory proteins, some of which 
function in response to transmembrane signals. To switch off actin assembly, ion-
activated control proteins such as gelsolin, severin and fragmin bind to the sides of 
filaments, sever bonds and cap filament ends to inhibit growth. Ponticulin and 
diacylglycerol have been implicated in helping to induce actin nucleation. Filament 
crosslinking molecules help incorporate actin into a three-dimensional network as the 
filaments elongate. In addition, tropomyosin and caldesmon bind to the groove of actin 
filament helix and stabilize it against spontaneous fragmentation. 
Both myosin I and II cause actin filaments to slide past one another in vitro. In a 
locomoting cell, they probably have distinct roles. Myosin I is located primarily at the 
front of the cell and is responsible for movement of vesicles and the plasma membrane 
associated with membrane ruffling. Myosin II is mainly concerned with contraction of 
the cortex (Bray 1992). This complex internal scaffolding is useless without all of the 
accessory proteins that link the three types of filaments to each other and to other parts of 
the cell. They strengthen the cytoskeleton by crosslinking and forming bundles within 
the cytoskeleton, and allow generation of internal movements of organelles using the 
filaments like tracks. 
Neural Tube Defects: Spina Bifida 
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All pregnancies carry a three percent risk for a major birth defect independent of 
any intrinsic or extrinsic factors (Buehler and others 1994). Neural tube defects (NTDs) 
are malformations affecting the brain and/or spinal cord that may or may not result from 
abnormal neural tube closure (DeSesso and others 1999). These defects occur in 1.3 to 
2.0 human fetuses per 1000 live births, representing the second most frequent congenital 
anomaly behind cardiac malformations (Wenstrom 1996). The range of prevalence is 
from 8 per 1000 for the British and the Sikhs, to 1 per 1000 in Lagos, Nigeria (Campbell 
and others 1986). 
The etiology of neural tube defects is multifactorial. The greatest risk factor for 
having an NTD-effected fetus is a previous pregnancy resulting in a NTD, increasing to 
10 times that of the general population. In women with two NTD pregnancies, the 
recurrence rate is approximately 10%, suggesting a genetic susceptibility (Lewis and 
others 1998). When studied, the inheritance pattern does not fit a single gene inheritance; 
the model is one of multigenic inheritance influenced by environment. Using a mouse 
model polymorphic for positioning of cranial neural tube closure site two, it was 
demonstrated that variation in the pattern of closure at this site is a genetically determined 
factor with the ability to influence the susceptibility of the embryo to cranial NTDs 
(Fleming 2000). 
Maternal illness and fetal drug exposure are also important factors in NTD 
development. At least 221 teratogenic agents have been associated with the production 
of NTDs in at least one species (De Sesso and others 1999). Other extrinsic factors that 
correlate to higher incidences ofNTDs are geographic region, maternal age and birth 
order, influence of socioeconomic class, and overall nutrition of the mother (Campbell 
and others 1986). 
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Spina bifida and anencephaly account for 50% and 40%, respectively, ofNTD 
cases (Lewis and others 1998). Spina bifida includes all abnormalities in which vertebral 
arches fail to close dorsal to the spinal cord to form the vertebral canal, and may or may 
not involve the spinal cord itself. There are several types of spina bifida ranging from no 
impairment to severe impairment. 
Spina bifida occulta is the most common and least severe type of defect. Below 
the skin, there is a localized gap in one or more vertebral arches, but the spinal cord and 
meninges remain entirely within the vertebral canal. The overlying skin may be normal, 
dimpled, pigmented, contain a lipoma, or have a tuft of hair. This usually does not 
present a neurological disorder as neural tissue is not directly involved, and the individual 
may not ever realize there is a defect unless an X-ray reveals it. Typical symptoms 
including muscle weakness and abnormal posture or gait are observed at the time when 
an affected child begins to walk; and bladder and bowel control problems are noted 
during toilet training (Buta 1975; Lewis and others 1998). 
Spina bifida cystica involves the neural tissue in the vertebral defect. There are 
two types. In meningocele, the dura mater and arachnoid maters protrude through the 
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defect in the vertebral arches forming a cystic swelling, but the cord and nerves stay 
within the vertebral canal. In meningomyelocele there is a cystic swelling, however the 
spinal cord is raised from the canal and is closely apposed to the wall of the swelling or 
its apex. Both meningocele and meningomyelocele are most common in the lower 
thoracic lumbar and sacral regions where the position and extent of defect determine the 
degree of neurological impairment. 
In spina bifida aperta (myeloschisis), the spinal cord takes the form of an open 
neural plate exposed to the external surface. This is the most common form of spina 
bifida seen in valproic acid exposed fetuses. In the more serious cases of spina bifida, 
there is partial or complete paralysis of the lower half of the body, partial or complete 
loss of bladder control, and absence of reflexes (Lewis and others 1998). 
The final form of spina bifida is anencephaly, caused by failure of the cephalic 
part of the neural tube to close. This lethal defect results in missing cerebral hemispheres 
and/or forebrain, with acrania always present. Other NTDs include encephalocele, 
protrusion of the brain through the cranium; and iniencephaly, failure of the occipital part 
of the cranium and upper spinal regions to close about the neural tube permitting 
exposure of cord and brain tissue (Lewis and others 1998). 
No animal model has been found that models human NTDs convincingly. The 
chick and mouse are used most often for studies because of the similarities during the 
process ofneurulation between them and humans. Typically, animal studies utilize 
naturally occurring defects to help us understand the normal closure mechanisms. They 
are also treated with known or potential human teratogens in order to elucidate their 
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mechanisms as well as furthering our understanding of the overall process of neurulation. 
The chick embryo has helped to show that the process of neural tube closure is a flexible 
process and NTDs may form by several different mechanisms within just one model. 
Campbell, Dayton, and Sohal's studies used the whole chick in ovo (1986) to show that 
4 7% of chicks with abnormally open neural tubes in the embryo develop neural tube 
defects when mature, that 14% with delayed neural tube closure developed NTDs, and, 
interestingly, that 3% of chicks with apparently normally closed neural tubes developed 
NTDs when mature. Overall, animal studies have given us many other clues about the 
causes ofNTDs. Naturally occurring or teratogenically produced failure of the neural 
tube to close may lead to NTDs. Single agents may increase or decrease the incidence of 
NTDs dependant on the time of treatment. Also, neural tube closure can be affected by 
agents with many different mechanisms of action (Campbell and others 1986). 
Cell Migration and NTD Formation 
Many types of cells must interact to correctly form an embryo, and these cells rely 
on signals from each other and from the environment in which they reside. Matrix and 
cell adhesion molecules, when disturbed at the time of neurulation, could be involved in 
the generation of NTDs by altering cell adhesion dependant morphogenic events 
(Newgreen and others 1997). The extracellular matrix molecules laminin, fibronectin, 
and chondroitin sulfate proteoglycan as well as the cell adhesion molecules E- and N-
cadherin, and N-CAM were examined in quail embryos with spontaneous NTDs. HNK-1 
was also used to label NCCs. In open NTDs, the early stages of normal primary 
neurulation with a sharp separation between E- and A-CAM expressing regions were 
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noted. Intervening matrix labeled less intensely for chondroitin sulfate proteoglycan 
relative to laminin and fibronectin when compared to control embryos. In closed NTDs, 
a band of matrix did not separate the dorsal superficial layer from the neural tube as in 
control embryos, and A-CAM and N-CAM were co-expressed with E-cadherin. In 
normal embryos, A-CAM and N-CAM are not found at this stage. The overlap region 
resembled the mid-dorsal tissue at earlier stages in normal secondary neurulation in the 
tail bud. Matrix molecules were found not around, but within the neural and epidermal 
epithelia in all of the defects. Lastly, unlike controls, HNK-1-labeled NCCs were 
frequently absent in regions ofNTDs. The authors concluded that matrix and cell 
adhesion molecules are disturbed in spontaneous NTDs during neurulation (Newgreen 
and others 1997). 
Role of Cell Proliferation in NTD Formation 
Normal cellular proliferation in the neuroepithelium plays an important role in 
proper neural tube closure. Numerous studies have demonstrated that when it is altered, 
NTDs can result (Copp 1988, 1990; Bennett and others 2000). For example, in the 
mouse mutant curly tail, 60% of ct/ct mutants develop spinal NTDs as a result of delayed 
neurulation (the other 40% develop normally). It is frequently used as a model system 
for neurulation investigations. When independent measurements of cell proliferation 
such as mitotic index, and median length of S-phase were studied, reduced rates of cell 
proliferation in gut endoderm and notochord cells in the neuropore region were indicated 
when compared to normally developing embryos. The incidence of cell death was not 
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consistently different from controls. This suggests the lowered rate of cell proliferation 
in these tissues is a mechanism ofNTD pathogenesis in curly tail embryos (Copp 1988). 
Valproic Acid 
Valproic acid, (2-propylpentanoic acid or dipropylacetic acid, VP A) is a simple 
eight carbon, branched-chain fatty acid (Figure 1 ). It is an anticonvulsant chemically 
unrelated to any other anticonvulsant drugs in that it lacks a nitrogen molecule or a 
heterocyclic functional group. 
CH3CH2CH2 
I 
CH3CH2CH2CHCOOH 
Figure 1 Structural formula ofVPA 
The discovery ofVPA as an anticonvulsant was unusual in that it was being used as a 
solvent to test other potential anticonvulsant compounds. All of the compounds seemed 
to have the same effect indicating that VPA itself had the ability to prevent seizures. It 
was released for use in 1967 in Europe, and was licensed in the United States by the FDA 
in 1978 for the treatment of absence seizures (Lammer and others 1987). By 1988, one 
million patients worldwide were on VPA therapy (Walmod and others 1998). It is known 
under the trade names Depakene (valproic acid), Depakote (divalproex sodium, sustained 
release form), and Depacon (intravenous form ofvalproate sodium). A popular drug 
because of its broad range of uses and relatively low occurrence of sedative and 
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behavioral side effects (Clayton-Smith and Donnai 1995), it has been mainly indicated as 
prevention or cure for myoclonic seizures, partial seizures, status epilepticus, tonic-clonic 
seizures, mania, and migraine (Browne 1980). Valproate also has been studied as 
treatment for anxiety, depressive, and psychotic disorders; alcohol withdrawal and 
dependence; tardive dyskinesia; agitation associated with dementia; and borderline 
personality disorder (Davis and others 2000). Approximately 35% of patients with 
schizophrenia received VP A as treatment in 1998 making it one of the most commonly 
prescribed for this disorder, second to lithium which had been the longstanding treatment 
(Citrome and others 2000). 
Bipolar disorder has been treated with lithium for over 30 years. Unfortunately 
this treatment has numerous negative side effects. For those patients requiring alternative 
treatment, recent data indicates that valproate is a well-tolerated and effective agent 
(Lennkh and Simhandl 2000; Mitchell 2000). A preliminary study using Divalproex 
treatment for explosive temper and mood !ability in disruptive children and adolescents 
showed eight out of ten subjects respondent to the drug, and zero of ten respondent to 
placebo (Donovan and others 2000). Two elderly women suffering from Charles Bonnet 
syndrome (pseudohallucinations in elderly people frequently suffering from reduced 
visual acuity) recently were successfully treated with valproate (Hori and others 2000). 
Mechanism of Action 
The exact mechanism ofVPA's beneficial effects is poorly understood. VPA has 
been shown to increase total brain and cerebellar levels of the inhibitory neurotransmitter 
gamma-aminobutyric acid (GABA) in the central nervous system. This inhibition has 
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been shown to correlate with the anti epileptic effect of VP A in some animal models of 
epilepsy (Browne 1980). VP A directly inhibits GABA transaminase, resulting in 
inhibition of GABA catabolism and decreases in sodium channel activity. It also blocks 
the reuptake of GABA into glia and nerve endings. It has demonstrated activation of 
glutamic acid decarboxylase (GAD), a major enzyme in GABA synthesis, and strong 
inhibition of succinic semialdehyde dehydrogenase, an enzyme in the GABA degradation 
pathway (Loscher 1993; Johannessen 2000). When GABA levels within the medial 
preoptic area in mice exposed to VPA were sampled, and it was found that: (1) VPA had 
regional specificity upon GABA levels, (2) a sex difference was present in the effects of 
VP A on GABA levels within the medial preoptic area, and (3) GABA levels increased in 
the afternoon of all days of the female estrous cycle, with VP A attenuating the rise seen 
on the afternoon of proestrous (Dodge and others 2000). Evidence also exists that 
suggests VP A reduces neurotransmission mediated by excitatory amino acids such as 
aspartic acid and gamma-hydroxybuteric acid. However, concentrations ofVPA greater 
than 5 mM enhanced rather than inhibited epileptiform activity induced by veratridine in 
rat hippocampal CAI pyramidal neurons (Otoom and Alkadhi 1999). 
VP A may also work by suppressing repetitive neuronal firing through inhibition 
of voltage sensitive sodium channels (Tunnicliff 1999). When high concentrations (5 to 
30 mM/L) of the drug were applied to Aplysia neurons, an increase in membrane 
potassium conductance developed, leading to an increase in membrane potential (Davis 
and others 1994). In vitro studies have shown that VP A is a potent inhibitor of succinate 
semialdehyde dehydrogenase, which is related to the tricarboxylic acid (TCA) cycle. 
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VP A might also inhibit the TCA cycle at the alpha-ketogluterate dehydrogenase step. 
The effect ofVPA on excitatory neurotransmission and on excitatory membranes is likely 
to be responsible for the mood stabilizing effect as well as in the treatment of migraine 
(Johannessen 2000). 
Dysregulation of central norepinephrine (NE) neuronal systems might be involved 
in the expression and development of major affective disorders, including bipolar 
disorder. The noradrenergic neurons of the locus coeruleus represent the source of 
noradrenergic terminals innervating many limbic and forebrain regions. These neurons 
are ideally placed to exert global modulatory or state-related changes in brain activity, 
and thus present potential targets for mood stabilizing drugs such as VP A (Sands and 
others 2000). It is important to note that the antiepileptic effects ofVPA are seen 
quickly, whereas the antimanic effects may take up to three weeks to be observed. This 
implies different mechanisms of action for the two effects. Sands and others (2000) 
suggest that gene expression of components of brain neurotransmitter systems, such as 
tyrosine hydroxylase (TH) are altered by VP A as it is with tricyclic antidepressents based 
on results of past studies. Adult male Sprage-Dawly rats were exposed to acute and 
chronic valproate treatment, and changes in the TH gene expression in the locus 
coeruleus were noted. Both treatments induced increases specifically in TH mRNA 
expression, with acutely treated responses less robust and inconsistent (Sands and others 
2000). It is possible that VP A exerts a direct pharmacological effect on gene expression 
in the NE system through stimulation of cellular effector processes and subsequent 
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activation of transcription factors. It is also possible that this is an indirect result exerted 
by changes in the GABAergic neurotransmission in the brain (Sands and others 2000). 
Several reports have indicated that anti-epileptic drugs including VPA affect the 
immune system. NF-kappaB is essential to the expression of the kappa light chain of 
immunoglobulin and proinflammatory cytokines. VPA inhibits NF-kappaB activation 
induced by lipopolysaccharide. VP A significantly inhibited lipopolysaccharide-induced 
production ofTNF-alpha and IL-6 production via inhibition ofNF-kappaB activation. 
These findings are consistent with the idea that VP A suppresses TNF-alpha and IL-6 
production via inhibition ofNF-kappaB activation (Ichiyama and others 2000). 
Evidence for Weak Teratogenicity 
Of the approximately 2.8 million Americans with epilepsy, 680,000 to 1.1 million 
afflicted women are of childbearing age (Yerby 1994). Pregnant women with epilepsy 
constitute 0.5% of all pregnancies (Nulman and others 1999). Dickinson and others 
(1979) showed that VPA crosses the placenta and the umbilical cord, resulting in 
newborn serum concentrations higher than found in maternal serum. Additional 
supporting evidence was provided by Nau and others in 1984. Embryonic mouse 
neuroepithelium showed higher uptake ofVPA than maternal blood, amniotic fluid and 
other embryonic tissues when 14C-VPA was administered to pregnant mice (Dencker and 
others 1990). Maternal plasma concentrations exceeding 1.6 mM have been shown to be 
necessary to produce exencephaly in the mouse (Nau 1986a). Human plasma 
concentrations after therapeutic application of VP A vary from 0.36 to 0.6 mM (K.ratke 
and Kirschbaum 1996). It is currently unclear exactly what level fetal serum 
concentrations are during embryogenesis. 
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The first adverse report of a human fetus exposed to the drug was in 1980. The 
exposed infant was born with low birth weight, hypoplastic nose, fronto-orbital ridges, 
and levocardia (Dalens and others 1980). In 1982, Robert and Guibaud reported from the 
Rhone Alps region that VP A was the cause of neural tube defects in children born to 
epileptic mothers on VPA therapy. Their data suggested a causal relationship between 
VPA and neural tube defects when administered during the first trimester of pregnancy. 
The estimated increased risk of a valproate-exposed fetus having spina bifida is 1-2% 
(Bjerkedal and others 1982). Clayton-Smith and Donnai described fetal valproate 
syndrome (FVS) in 1995. They defined a set of anomalies associated with VPA 
exposure. They are neural tube defects (spina bifida), congenital heart defects, oral 
clefts, genital abnormalities, and limb defects. Other less frequent abnormalities included 
abdominal wall defects, tracheomalacia, and strabismus. The most common neural tube 
defect was spina bifida with a predisposition for very low lumbar or sacral defects 
suggesting that valproate affects primarily the lowest closure site of the neural tube 
(Clayton-Smith and Donnai 1995). Congenital heart defect incidence is estimated to be 
around four times that of the general population. Both septal defects and valvular 
problems have been reported. These reports are not as consistent as with the neural tube 
defects. Oral clefts have also been observed in children of mothers on valproate 
monotherapy (Clayton-Smith and Donnai 1995). 
39 
Multiple reports since 1976 have shown VPA to be a potent teratogen in the 
rabbit, mouse, rat, hamster, axolotl, and chick. The fact that VP A affects so many 
species makes a causal relationship in humans more biologically plausible (Lammer 
1987). A review of nine studies using whole embryo rat and mouse culture by Gofflot 
and others (1995) reported a series of macroscopic malformations. The list in order of 
high to low incidence included: unfused brain folds, irregular brain structure, abnormal 
curvature, stunted fore brain, irregular segmentation of the somites, decreased yolk sac 
vasculature, abnormal otic system, abnormal optic system, irregular shape of the head, 
underdeveloped branchial bars, and posterior neuropore closure defects. In both rats and 
mice exposed to VP A during organogenesis, developmental defects of the digits and axial 
skeleton were produced. Exencephaly was also produced, but only in mice (Narotsky 
and others 1994). 
Although spina bifida is the primary NTD seen in humans, in animal models VP A 
induces exencephaly (an anterior neural tube defect) much more frequently (Lammer 
1987; Nau 1994). VPA administration during embryogenesis in the mouse also results in 
oral clefts, increased embryolethality, and reduction of fetal weight (Nau 1986b). 
Lumbosacral spina bifida aperta with accompanying tail malformations and spina bifida 
occulta can be produced in mice at a significant rate when exposed to VPA. Specifically, 
the closure of the lumbar and sacral/coccygeal vertebrae is inhibited. Developmental 
delay was not a factor in these malformations (Nau 1994). The spina bifida aperta 
morphology and period of sensitivity are different for VP A and retinoic acid in the mouse 
fetus. It is possible that there are differing mechanisms of spina bifida induction between 
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these two teratogens (Ehlers and others 1992). There are also strain differences noted 
concerning VP A-induced formation of neural tube defects, indicating a clear genetic link 
to VPA susceptibility in the mouse (Nau 1994). 
When the histological structure of the murine hindbrain neuroepithelium is 
observed after treatment with VP A, two modifications are noted. In all treated embryos, 
there appeared to be a dilation of the area characterized by increases in surface and lateral 
bulges on both sides of the neuroepithelium. These bulges sometimes presented two or 
three irregular disorganized lobes. Other alterations included increased number of cells 
or cell debris in the lumen of the brain vesicles and optic stalks, and an increase of the 
protruding cell contour on the ventricular surface of the neuroepithelium. More 
abnormalities were noted. Irregular suture line was observed at all levels of the caudal 
neural tube. The wavy, zigzag or irregular types of sutures were not random, and had not 
been previously described (Gofflot and others 1994). A survey of nine studies using 
whole embryo culture demonstrated that VP A affects rat neural tube and brain 
development as well. Asymmetric layers of neural epithelium, incomplete neural fold 
fusion, general neural tube irregularities, and incomplete and irregular segmentation of 
brain vesicles occurred when embryos were exposed to VPA (Gofflot and others 1994). 
Somites in the chick embryo are affected by VP A. The Pax family of pattern 
forming genes, specifically Pax-1, have been demonstrated to be regulators of axial 
skeletal patterning at the somite level. VP A causes malformations in chick somite 
development in a dose dependent manner. Large somite disorganization patterns, mis-
segmentation of the somites, or fusing of somites together are seen. In these embryos, 
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Pax-1 expression was lowered according to Northern Blot analysis. In situ hybridization 
revealed that areas of malformed somites corresponded to areas of low Pax-1 expression. 
Embryos with Pax-1 gene expression altered using an anti-sense oligoneucleotide 
exhibited similar malformations when compared to VP A treated embryos (Barnes and 
others 1996). 
In the amphibian Ambystoma mexicanum, VP A caused retarded development, 
heart malformations, and neural tube defects, some of which resembled exencephaly. 
Continuous treatment resulted in more consistent and serious developmental disturbances 
than did pulse treatment. Neurulation was retarded and neural fold closure was disturbed. 
The neural epithelium was disorganized and its cells were less elongated than normal. 
Intercellular spaces in neural epithelium as well as in connective tissue were enlarged and 
cell adhesion seemed to be disturbed in both tissues. Oversized somites appeared with 
treatment, periodically filling the space between the notochord and notoplate, while the 
notochord itself seemed undisturbed. During 2.0mM continuous exposure, NCC 
derivatives were not detectable in the embryos. The nature of these disturbances may 
indicate an interaction between the drug and components of the extracellular matrix and 
the cytoskeleton in non-mammalian cells (Kratke and Kirschbaum 1996). 
Nau and Spielmann in 1983 showed similar doses of VP A can have unique fetal 
effects depending on the administration schedule. Peak concentrations of VPA can be 
related to the teratogenicity in the mouse in that a particular threshold concentration, 
approximately 230-250µg/ml (1.67 mM) mouse serum, must be reached before neural 
tube defects are formed (Nau 1985). 
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Four metabolites ofVPA, 2-en-VPA, 4-OH-VPA, 5-OH-VPA, and 3-keto-VPA 
were administered to pregnant mice to determine the teratogenic potential of each. 
Metabolite concentrations were much lower than VP A. MetaboliteNP A ratios were 
generally between 0.001 and 0.02. Further, the metabolites did not accumulate in 
embryonic tissues, unlike VP A. It was determined that the parent drug, and not one of 
the four metabolites tested, was the principle teratogen in mice (Nau 1986b). 2-en-VPA, 
VP A's main pharmacodynamically active metabolite, had a particularly low teratogenic 
potential. Heinz Nau (1986a) demonstrated that the low teratogenic and embryotoxic 
potential of this metabolite is due to intrinsic activity of the compound, and not just lower 
peak concentrations found in mother and embryo. The peak maternal serum 
concentrations for VP A were only slightly higher than 2-en-VP A. They concluded this 
difference was clearly not enough to account for the large difference between the 
teratogenicity of the two compounds (Nau 1986b). With further study, this compound 
may become an acceptable substitute for VP A in female patients trying to conceive. 
Mechanisms ofTeratogenesis 
The mechanisms of neurulation and spontaneous NTD formation have not been 
entirely understood. In addition, the exact biochemical mechanism of most teratogens, 
including VP A, is not known. Several hypotheses are being investigated to identify the 
mechanism(s) ofVPA's teratogenicity. These hypotheses include interference with 
embryonic lipid metabolism, interference with zinc metabolism, and interference with 
neurotransmitter metabolism (Clarke and Brown 1987; Wegner and others 1990; Nau 
1994). Another hypothesis examines alteration of intracellular pH, which is an important 
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parameter of numerous cellular functions and seems to be a promising area of study 
because the early mammalian embryo has a relatively high intracellular pH and may then 
accumulate acidic compounds such as VP A via ion trapping (Scott and others 1990 cited 
in Nau 1994). Lastly, interference with embryonic folate metabolism is currently being 
investigated (Nau 1994). It has been widely documented that folate taken before and 
during pregnancy reduces the risk of neural tube and neural crest defects including failure 
of neural tube closure, orofacial defects and heart septation anomalies. Folate 
concentrations decrease during pregnancy, and treatment with antiepileptic drugs such as 
VPA can intensify this effect (Hendel and others 1984). Teratogenic doses ofVPA 
induced a characteristic dose-dependant alteration of embryonic folate metabolism. The 
amounts of formylated folates decreased, while the amount of tetrahydrofolic acid (THF) 
increased. This relative change in folate metabolite concentrations suggests that the 
interconversion between THF and 5-CHO-THF may have been inhibited by VP A. These 
results indicate that interference with embryonic folate metabolism may be involved in 
some aspects ofVPA teratogenesis (Nau 1994). The protective mechanism offolic acid 
is unknown at the cellular level. 
Increased homocysteine levels are detected with folate deficiency, and it has been 
hypothesized that homocysteine per se might be the teratogenic agent. Indeed folic acid 
supplementation is effective in preventing neural tube and other defects only when 
homocysteine levels are concomitantly reduced (Rosenquist and others 1996). Induction 
of neural crest and neural tube defects is a general effect of N-methyl-D-aspartate 
(NMDA) receptor antagonists. Proteins involved in functional NMDA receptors are 
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present as early as stage 10 in the chick. There is evidence from later stages of 
development that the NMDA receptor is a regulator of neuronal cell migration, cell-cell 
adhesion, and apoptosis (Komuro and Rakie 1993; Rashid and Cambray-Deakin 1992; 
Balazs and others 1989). The NMDA receptor antagonists ethanol and VP A have been 
identified as possibly contributing to NTDs by competitive inhibition. Homocysteine has 
also been found to act as an NMDA receptor antagonist in avian embryos. Homocysteine 
induced neural tube, conotruncal, and orofacial malformations in a dose and time 
dependant manner. Rosenquist and others (1999) have demonstrated that of three 
agonists introduced in combination with homocysteine, glycine is the most effective, 
significantly reducing defects at two different doses. Due to the similarity of 
deformations between these three antagonists, similar teratogenic mechanisms involving 
the NMDA receptor may be at work. 
In addition to folate supplementation, methionine supplementation appears to 
inhibit NTD formation, indicating it may also play a role in NTDs. A study by Hishida 
and Nau (1998) demonstrated that in mice, 30 minutes after VPA treatment, significant, 
dose dependant decreases in serum methionine and serine levels are noted, while 
homocysteine and cysteine were increased via accelerated conversion of methionine to 
homocysteine. There was also an inhibition ofhomocysteine remethylation due to folate 
metabolism deficiencies, an increase of aminothiols, and a depression of (chemically) 
reduced glutathione. They suggest that alteration of amino acid metabolism could 
contribute to VPA's teratogenicity in at least four ways: (1) deficiency of methionine, 
which is requisite for neural tube closure shown by in vitro studies; (2) increased levels 
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of homocysteine becoming toxic through production ofreactive oxygen species; (3) 
increased levels of cysteine, known for its radioprotective and antioxidant roles, 
becoming toxic when redox metal ions are present resulting in reactive oxygen species; 
and ( 4) reduction in the reduced form of glutathione (GSH) which is an important 
protector against reactive oxygen species during early development. They hypothesize 
that folate supplementation may prevent NTDs via elevation ofhomocysteine 
remethylation to methionine (Hishida and Nau 1998). In a study of 62 patients on AED 
monotherapy however, only seven had hyperhomocysteinemia, and none of these was on 
valproate therapy. However, in 54% of those on valproate there were lower than normal 
(12.0 nmol/1) plasma folate concentrations. Serum vitamin B-12 concentrations were 
significantly elevated only in patients on valproate therapy in this study, supporting 
several other studies' findings. The mechanism of this elevation is currently unknown 
(Tamura and others 2000). 
In 1995, Sato, Shirota, and Nagao reported the first evidence that pantothenic acid 
(PT A), when coadministered with VP A, significantly decreased exencephaly in the 
mouse. PT A is essential for a developing animal; deficiency results in neural tube 
defects and growth retardation. VP A induced a dose dependent increase in exencephaly 
as well as a significant rate of rib, thoracic, and sternebral malformations when compared 
to controls. PTA coadministration resulted in significant decrease in exencephaly rates, 
but did not appear to decrease any types of skeletal malformations. Conversely, folic 
acid has been demonstrated to reduce rib and sternebral abnormalities. This may indicate 
two differing mechanisms of protecting against neural tube defects (Sato and others 
1995). 
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Several lines of investigation have led to evidence that the mammalian neural tube 
closure initiates in at least four discrete locations. Failure of closure in any of the sites I 
through IV may result in the differing types and locales of spina bifida. Disrupted 
closure site-specific genetic processes may contribute to some NTDs. There are few 
genes identified as having roles in these closure sites that may be affected by teratogens. 
One of these, coding for the cell cycle enzyme ribonucleotide reductase subunit Rl (rnr-
r l ), has recently been identified as a VPA-sensitive gene. Using the inbred mouse strain 
SWV /Fnn, which has a high susceptibility to VP A-induced NTDs in closure site II, a 
VP A-sensitive closure site II-specific clone was identified and confirmed to code for rnr-
rl. VPA drug treatment significantly increased the amount of rnr-rl mRNA along with a 
significant decrease in cellular proliferation in the closure site II neural tube region of the 
embryos. Rnr-rl appears to play a critical role in exencephaly induced by VPA (Craig 
and others 2000). 
Neurulation in the early chick embryo is also affected by VPA. Concentrations of 
0.5-1.5 mM VPA caused a dose dependent increase in the incidence of open anterior and 
posterior neuropores. Greater concentrations increased the number of complete 
disruptions of the neural tube along its entire length. These defects do not appear to be 
related to developmental delay and they were not repaired with continued incubation time 
(Kelly and Regan 1992). 
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In older chick embryos, the noncytotoxic effects of VP A on vertebral 
chondrocytes during spine formation were investigated (Basu and Wezeman 2000). VPA 
significantly lowered expression of type IX collagen and aggrecan core protein mRNA 
levels. This alteration in these critical genes expressions during vertebral chondrogenesis 
may be related to the failure of neural arch development in lumber spina bifida (Basu and 
Wezeman 2000). 
While studying the genetic basis for VP A teratogenicity in mice, Failla and others 
(2000) discovered that parental factors influence fetal susceptibility to induced 
malformations. Results of reciprocal crosses between teratogen susceptible and resistant 
strains of mice suggested that the maternal genotype was more strongly associated with 
VPA-induced teratogenicity than was the paternal genotype. The nature of this paternal 
factor is unknown. Morphological analysis of the VPA-treated fetuses revealed the 
presence ofhomeotic transformations generally in the lower thoracic and lumbar regions, 
but not the cervical or upper thoracic segments. Penetrance and localization ofVPA-
induced malformations varied among six strains tested. Malformations seen in the 
lumbar, sacral, and appindicular regions of treated embryos were consistent with those 
expected after dysregulation of the 5' Hox genes during early development. This altered 
gene expression may disturb positional cues for closure of the posterior neuropore (Failla 
and others 2000). 
VP A has been shown to inhibit the proliferation of neuronal cells in culture and 
recent studies have been carried out to determine the explanation. The proliferative rate 
of C6 glioma cells has been inhibited in a dose dependant manner using a 1 mM 
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concentration to achieve 50% inhibition. This effect was reversible and, at the 
concentration utilized, could not be attributed to cytotoxicity. When present, VPA 
interrupted the cell cycle 5 hours into the G 1 phase, 6-6.5 hours prior to S phase. S-phase 
entries by cells past this restriction point were not affected by VP A exposure (Martin 
1991). 
To determine the potential mechanism of the antiproliferative effect ofVPA, 
transcriptional activities of genes coding for several growth factors, receptors and 
neurotrophic factors was investigated by Bennett and associates (2000). They used two 
VPA sensitive strains of mice, LM/Bc (less) and SWV (more), and found that 
transcriptional activity of neurotrophic and growth factor genes were altered during 
neurulation in the presence ofVPA. The pattern of alterations suggested that the high 
incidence of teratogenicity in the SWV strain of mice might be due to suppression of 
proliferation in the neuroepithelium. Interestingly, they also found that these two strains 
behaved differently under control conditions, supporting the multifactorial explanation of 
NTD formation. 
VP A Effects Cell Motility and the Cytoskeleton 
Walmod and others (1998) performed experiments on L-cells in 3.0 mM 
treatment ofVPA and two analogues, (E)-2-en-VPA and (±)-4-en-VPA. The migration 
of the cells was tracked for 10 hours using video recordings and it was found that cellular 
migration was inhibited in a dose dependant manner for all three compounds, inversely 
correlated to each compound's teratogenicity. The inhibition was not dependent on the 
clone of L-cells and was independent of the culture substratum. 
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To determine to what extent VPA was inducing migratory inhibition, RGD-
containing peptide rescue treatment was carried out. Treatment with an RGD-containing 
peptide, reducing integrin binding to components of the extracellular matrix, partially 
reverted the motility inhibition induced by VP A. It was therefore shown that increased 
attachment was contributing to decreased motility, but it was not the sole cause (Walmod 
and others 1999). It was shown that the actomyosin cytoskeleton ofVPA-treated cells 
was capable of contraction upon exposure to ATP, indicating that the reduced motility 
was not caused by inhibition of actomyosin contraction. Gelsolin is an essential protein 
involved in F-actin dynamics responsible for severing and capping actin fibers. It was 
found that long term exposure to 3 mM VP A lead to redistribution of gelsolin from the 
peripheral membrane ruffles ( control) to a diffuse perinuclear localization (treated). 
When control cells were incubated with a decapeptide containing one of the 
phosphatidylinositol biphosphate (PIP2) binding motifs of gelsolin, leaving the gelsolin in 
a potential actin binding state, a strong rounding response was seen, resulting in brighter 
cells. In contrast, VP A treated cells exposed to the peptide were not significantly more 
rounded, and insignificant changes in brightness were noted. VP A appears to leave L-
cells in an unresponsive state to a PIP2 binding motif Walmod and others suggest that 
the VP A-induced alteration in gelsolin regulated dynamics of actin filaments contribute 
to the reduced motile behavior and altered morphology of VP A treated cells and, 
therefore, possibly to the teratogenic potential of the compound (Walmod and others 
1999). Confocal micrographs of fluorescence staining ofmicrotubules, F-actin, and 
selected focal adhesion proteins demonstrated that VP A-exposure caused an enhanced 
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focal adhesion formation accompanied by a rearrangement ofF-actin reflected by an 
increase in stress fiber formation (Walmod and others 1998). In control cells, F-actin was 
mainly present as a cortical mesh, whereas in the treated cells, there were numerous stress 
fibers often with a perinuclear distribution. Organization patterns of the cytoskeleton are 
a major factor in cellular morphology. Both treated and untreated cells demonstrated a 
well-developed scaffold ofmicrotubules whose organization did not seem to be affected 
by VP A. In addition, treated cells seemed to be devoid of micro spikes, which were 
observed in great numbers in control cells. Mechanical tension generated within the 
cytoskeleton and transmitted to the exterior via cell-cell and cell-ECM interactions have 
been demonstrated to effect cellular morphology, motility, and morphogenesis (Ingber 
and others 1994). 
It has been revealed that VP A causes alterations in the focal adhesions and actin 
cytoskeleton offibroblastoid L-cells. VPA and VPA- analogues have been demonstrated 
by Berezin and others (1996) to increase mean cell area of cultured fibroblastoid L-cells 
in correlation with the teratogenic potential of each analogue tested. W almod and others 
(1999) demonstrated that after treating L929 cells with 3mM VPA or sodium valproate 
for 48 hours there was increased flattening and spreading of the cells compared to 
control. Overall, the cells were larger and had more and/or longer processes. Relative F-
actin per cell was calculated and found to be significantly higher (23%) for treated cells. 
F-actin distribution was altered indicated by an increase amount of stress fibers, and a 
decrease in cortical F-actin and lower numbers of membrane ruffles. Treated cells also 
had more pronounced focal adhesion proteins at the ventral surface, indicating more 
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pronounced adhesion. In focal adhesion complexes, VP A treatment induced an increase 
of phosphotyrosine, paxillin, vinculin, and focal adhesion kinase (F AK). When these 
were visualized with appropriate antibodies, they were found in oblong patches more 
strongly manifested in treated than control cells, where cytosol staining was more diffuse 
(Walmod and others 1998, 1999). This indicated that a higher proportion of these 
proteins had been directed to the focal adhesion sites. This supports the hypothesis that 
VPA might cause a decrease in cell motility through increased cell-substratum adhesion 
(Walmod and others 1999). 
It has been reported that expression of the neuronal cell adhesion molecule N-
CAM is upregulated in human neuroblastoma cells upon exposure to VPA (Cinatl Jr. and 
others 1996) while other cell adhesion molecules such as ICAM-1, VCAM-1, ELAM-1, 
and LFA-3 were not. The effect may reflect changes in the cell adhesion mechanism 
(Walmod and others 1988). Increased cell-cell adhesion may additionally contribute to 
VP A induced NTDs. VP A has been demonstrated to induce expression of a collagen 
type IV receptor in C6 glioma cells and astrocytes in primary cultures (Martin and Regan 
1988). It has also been shown that VP A modifies the extracellular matrix in a three 
dimensional agarose gel culture of human chondrocytes, reducing the amount of collagen 
type II and increasing the deposition of collagen type I (Aulthouse and Hitt 1994). 
CHAPTER2 
MATERIALS AND METHODS 
Isolation and Culture ofNCCs 
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Fertilized Red Rock hen eggs (Whelp, Inc., Bancroft, IA) were incubated 30-35 
hours at 37° C with high humidity to obtain embryos at Hamburger-Hamilton stages 10-
through 1 o+ (Hamburger and Hamilton 1951 ). Embryos were located and removed from 
the egg using a ring of Whatman 3MM chromatography paper (Whatman Int. LTD, 
Maidsrone, UK). The adhered embryo was immersed in Earle's Balanced Salt Solution 
(EBSS) (Sigma, St. Louis, MO) and warmed to 38° C for microdissection with glass 
needles as previously described (Wiens and others, 1992; Orris and Wiens, 1998). Trunk 
neural fold explants were obtained by making incisions midsagittally between neural 
folds, lateral to each, and then across the entire neural tube at the cranial end and at the 
eighth intersomitic groove (Figure 2). 
Figure 2 Stage 10 embryo as seen for microdissection. Black rectangle indicates area of trunk 
neural folds to be removed for culture. White arrow indicates somites used for stage 
identification. Magnification: 1 Ox. 
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Neural tubes were removed from the embryos and placed into a fresh dish of 
EBSS. The notochords were dissected away leaving the left and right neural folds. Each 
was separated into 2-4 pieces approximately the length of two somites. One neural fold 
was cultured in Medium 199 with HEPES modification, pH 7.35 (Sigma, St. Louis, MO), 
supplemented with 1 % antibiotic/antimicotic (Sigma, St. Louis, MO), 10% fetal bovine 
serum (Sigma, St. Louis, MO), and 5% donor horse serum (Atlanta Biologicals, Nacross, 
GA). The other was cultured in the same medium but with either 0.75, 1.5, 2.0, or 3.0 
mM valproic acid (Sigma, St. Louis, MO) added from a stock of0.75M or 1.0 M 
solution. This corresponds to a range found to be experimentally effective in previous 
studies and corresponds to serum concentrations found in human plasma after therapeutic 
VPA dosage (Goffiot et al. 1995; Kratke and Kirschbaum 1996; Walmod et al. 1998). 
Both were incubated in 35 mm Falcon Primaria culture dishes (Falcon, Becton-
Dickenson, Lincoln Park, NJ) for 24-48 hours. For experiments intended for 
immunostaining, the same procedure and media were utilized. During this time, explants 
adhered to the culture surface, and NCCs migrated outward from them in all directions. 
Image Capture 
In order to collect motility and morphometry data, after 24 hours of culture, the 
dishes were removed from the incubator and immediately placed in a preheated 
aluminum block stage warmer on an Olympus CK2 inverted phase contrast microscope 
equipped with a Hitachi 3 CCD video camera. A field of 15-50 isolated migratory NCCs 
were identified at l00x and 14 sequential images were captured with an MVC PCI frame 
capture board (Imaging Technology, Bedford, MA) at three minute intervals using 
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Optimas imaging software, version 6.0 (Optimas Corporation Inc., Bothell, WA). Dish 
temperature was maintained at 38° C throughout the image capture period for optimum 
NCC migration capability. The images files were stored on the hard drive of a Gateway 
PS-166 computer, with copies on Iomega 100MB Zip disks (Iomega Corporation, Roy, 
Utah). 
In order to determine total cell counts; proportions of flat, rounded, clustered, and 
independent cells, and assess overall explant morphology, single 40X images of the 
explants were also captured as before the dishes were fixed for immunochemistry. 
Motion Analysis 
The Optimas program was utilized to extract area morphometry and motion 
analysis data from each series of control or VP A-treated images. Each series of frames 
was opened in Optimas version 6.0 (Optimas Corporation Inc., Bothell, WA) and 12-14 
isolated, flattened migratory cells were selected for analysis. Those that were rounded, 
had migrated out of the field of view, or were not clearly visible in any one of the frames 
were excluded from analysis. Each individual cell chosen for analysis was manually 
assigned a unique label to maintain correct data collection and export throughout data 
collection. The program was calibrated to take all measurements in micrometers. Using 
the computer mouse, each cell border was traced by hand for maximum accuracy 
(Figure 3). 
Figure 3 Computer generated image of migratory NCCs 
cultured in the control condition. The periphery of the cell has 
been traced for morphometry and motion analysis. Image 
captured at 1 00x. 
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Optimas calculated the area, perimeter, circularity, maximum length, maximum width, 
velocity, and distance traveled between frames for each of the 10-14 individual traced 
cells for the fourteen frames. These values were then exported to the spreadsheet 
program Microsoft Excel. Area was defined as total area of an object within the 
perimeter outline. Perimeter was defined as total length of the perimeter of the area 
object. Centroid (center point) position was found by averaging all X and Y coordinates 
of pixels within the traced area, and using the single mean X and Y coordinates to define 
the centroid of the object. Circularity of each traced area was calculated as the ratio of 
the perimeter length squared, divided by the area (a minimum value of four 7t would only 
be obtained by true circles). Maximum length was defined as the longest axis of the 
outlined area. Width was the greatest distance measured perpendicular to the longest 
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axis. Distance traveled between frames was defined as the distance the cell's centroid 
had been displaced between successive frames. Velocity was defined as the displacement 
of the cells centroid between frames divided by the time between frames. For statistical 
analysis of area, perimeter, circularity, maximum length, maximum width, velocity, and 
distance traveled between frames, the mean parameter value was found per frame for all 
cells traced within that frame, resulting in 14 values for corresponding to the 14 frames in 
the 'movie'. 
Elongation index, total distance migrated, dynamic change in area, and dynamic 
change in perimeter were manually calculated using the original exported data from 
Optimas, then added to the Excel spreadsheet for analysis. Elongation index was 
calculated in Microsoft Excel by dividing the width by the length of the cell. For 
statistical analysis, the mean elongation index value was found per frame for all cells 
traced within that frame, resulting in 14 values for corresponding to the 14 frames in the 
'movie'. Total distance traveled was the sum of the distance traveled between successive 
frames for each cell. This resulted in 10-14 values, depending on the total number of 
cells selected for analysis in each particular movie. Dynamic change in area was 
calculated by finding the absolute value of the difference in area for each cell from frame 
to frame. The mean dynamic change in area was figured for all cells between each frame, 
resulting in 13 values for the 14 frame series. Dynamic change in perimeter was 
similarly calculated by finding the mean absolute value of the difference in perimeter for 
all cells in each frame resulting in 13 dynamic change in perimeter values. 
57 
Statistical Analysis 
Measurements taken using the Optimas program were exported to Microsoft 
Excel for management, comparison, and descriptive statistics. For area, perimeter, 
circularity, width, length, and elongation index, the mean values for all cells were found 
per frame resulting in 14 values for either drug or control series. The differences between 
control and drug-treated cells were tested for significance utilizing the Wilcoxon rank 
sum test for nonparametric data. Velocity, total distance, change in distance migrated 
between frames, total distance migrated, total dynamic change in area and dynamic 
change in perimeter were all found for each individual cell for fourteen frames, resulting 
in 10-14 values based upon number of cells traced. The differences between control and 
drug-exposed cells were then tested for significance utilizing the Wilcoxon rank sum test 
for nonparametric data. For all tests, the approximate normal deviate IZ! with a 
corresponding P value less than or equal to 0.05 was considered to be significant. 
Immunohistochemistry 
Monoclonal Anti-A-Cell Adhesion Molecule (A-CAM) antibody (Sigma, St. 
Louis, MO) was used to visualize N-cadherin at the cell junctions. This antibody 
localizes a 135 kD calcium-dependant adhesion molecule associated with intercellular 
adherens junctions in several species including chicken (Volk and others 1990). This 
antibody reacts with the N-terminal half of the extracellular domain of A-CAM (Volk 
1984, 1990). Cultured explants were washed in PBS at 37°C and then fixed in 20% 
DMSO in methanol for 30 minutes. After PBS washing, 0.1 % Triton X-100 in PBS was 
added for 3 to 5 minutes to permeabilize the cells. Blocking was done by incubating for 
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30 minutes in serum blocking solution, reagent lA in the Zymed Histostain SP kit 
(Zymed Laboratories Inc., San Francisco, California). Incubation with Monoclonal Anti-
A-CAM antibody (Sigma, St. Louis, MO) was performed for 30 minutes at 37° C with 
100% humidity or overnight at 9°C with high humidity. Primary antibody was then 
removed, and the cultures were washed three times in PBS. Biotinylated secondary 
antibody, Biotin-Goat Anti-mouse IgG, (reagent lB from the Zymed kit), was added for 
30 minutes. Then the cultures were washed in PBS as before. In the dark, CY3-
Streptavidin (Zymed Laboratories Inc., San Francisco, CA) was added to the cultures for 
10 minutes at room temperature. The cultures were thoroughly washed with PBS and 
mounted in antifade mounting media, 5% n-propyl gallate (Sigma, St. Louis, MO), 25% 
0.5M Tris pH 9.0, and 70 % glycerol. After drying overnight in the dark, the edges of the 
coverslips were sealed with Permount (Fischer Scientific, Fair Lawn, NJ). Images of the 
explants were captured both with phase-contrast optics and fluorescence on an Olympus 
BX40 microscope equipped with a 3 CCD video camera system (Optronics Engineering, 
Goleta, CA) for low light image capture. The fluorescence images were captured with a 
manual shutter speed of 2. The images files were stored on the hard drive of a Gateway 
PS-166 computer, with copies on Iomega 100MB Zip disks (Iomega Corporation, Roy, 
Utah). 
Fluorescein isothiocyanate (FITC)-labeled phalloidin (Sigma, St. Louis, MO) was 
used to reveal the filamentous actin in cells. This phallotoxin binds and stabilizes 
filamentous actin (Wulf and others 1976). Explants were washed in PBS at 37°C then 
fixed in 3. 7% formaldehyde for 10 minutes. After PBS washing, 0.1 % Triton X-100 in 
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PBS was added for 3-5 minutes with gentle agitation to permeabilize the cells. In the 
dark at room temperature, 100µ1 of a 5 µg per ml solution of FITC-phalloidin was added 
to each dish for 60 minutes. The cultures were thoroughly washed with PBS and 
mounted in antifade mounting medium (33% w/v glycerol, 13.3% w/v Mowiol (Aldrich, 
Milwaukee, WI), 0.13 M Tris buffer, pH 8.5). All slides were kept in the dark at 4°C 
until images were taken of the cells. Images of the explants were captured with 
fluorescence optics on the Olympus BX40 microscope equipped with a 3 CCD video 
camera system (Optronics Engineering, Goleta, CA) designed for low light image capture 
using a manual shutter speed of 1. The images files were stored as above. 
Proliferation Assay 
Neural fold explants were cultured as described for 24 hours. At that time the 
initial culture medium was replaced with media containing a 10·2 M solution of 
bromodeoxyuridine (BrdU) diluted 1: 1000. After 2 hours of incubation, cultures were 
washed 2 times with 38°C PBS and visualization ofBrdU incorporated nuclei was 
performed using reagents and methods from the Zymed BrdU staining kit (Zymed 
Laboratories, San Francisco, California). The dishes were mounted with a plastic 
coverslip in Gelmount from the kit and allowed to dry overnight. The total number of 
cells that had migrated from the explants was counted with a hand-held counter while 
viewing on an AO binocular microscope at 150x magnification. The number of 
emigrated NCCs positive for BrdU, indicated by purple-brown stained nuclei, was 
counted and a percent of total positive emigrated cells was then calculated. A Student's 
T-test was used to determine if percent stained was significantly different between 
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control and VP A-treated cultures. Using Optimas imaging software (Media Cybernetics, 
Bedford, MA), images were captured with a Hitachi 3 CCD video camera from an 
Olympus CK2 inverted phase contrast microscope and stored as before. 
CHAPTER3 
RESULTS 
The Effect of VPA on NCC Emigration and Explant Morphology 
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Neural fold tissues were dissected from embryos and placed into Primaria culture 
dishes for a 24-27 hour incubation period during which the explants adhered and cells 
began to migrate outward. At that time computer images were taken of some explants at 
40X and 1 00X and stored on Iomega Zip disks and on the hard drive of a Gateway PS-
166 computer. Control explants adhered to the Primaria surface and migrating cells were 
noted around the explant in at least 95% of cases. Explants cultured in the presence of 
0.75 mM, 1.5 mM, and 2.0mM VPA had a 75-90% attachment rate with emigrating cells 
apparent after 24 hours. Explants cultured in the presence of 3.0 mM VPA had an 
attachment rate of about 50%, and of those approximately 40% had any cells migrating 
outward. 
In control dishes scored for number of emigrated cells, an average of 275 cells per 
explant (range, 74-998) was found. The vast majority of these cells were independent, 
flat and demonstrated typical motile cell morphology (Figure Sa). Approximately 2-5 % 
were rounded and 5-10% were in clusters or sheet-like groups. The explant in the center 
of the carpet of cells was easily distinguished, having a distinct border and round or 
curved morphology. Approximately 5% of the control explants had 25% or less of their 
cells in an epithelial sheet formation extending from the explants edge. 
In 0.75mM VP A-treated explants scored for number of emigrated cells, there was 
an average of218 cells emigrated per explant with a range of 45-718. Slightly less than 
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half of the emigrated cells were independent, with 2-5% of those rounded, and the rest 
contained in epithelial sheets extending from the explant. The sheet comprised 25-75% 
of the explant's border; with the remaining portion a distinct boundary between explant 
and culture surface. Not every explant displayed some epithelial sheet morphology; 20-
25% were similar to controls. 
In 1.5 mM VP A-treated dishes scored for number of emigrated cells, an average 
of247 per explant (range, 24-920) was calculated. In 2.0 mM VPA-treated dishes, an 
average of 133 cells per explant was recorded (range, 61-215). For both 1.5 and 2.0 mM 
VP A-treated groups, the number of explants displaying the epithelial sheet morphology 
around at least half of the explant was 70-75%. Some of the explants had two sheets on 
opposing sides, and some of these sheets curved around the explant in a wing shape (see 
Figure 1 la). The remaining explant border was distinct and may or may not have had 
independent migratory cells around it. Also, seen in some 1.5 and 2.0 mM VP A-treated 
dishes, were completely flattened explants totally surrounded by an epithelial sheet, 
having no distinguishable border between the edge of the explant and the beginning of 
the sheet (Figure 5b ). These explants had no independent cells outside of the sheet at all. 
In 3.0 mM VPA-treated dishes that had attached explants with emigrated cells, an 
average of 121cells per explant (range 0-321) were found. The occurrence of an 
epithelial sheet around the explant was seen in only 5-10% of cases. Most explants with 
migrating cells resembled control cells morphologically, although the overall density of 
cells in the carpet surrounding the explant seemed less. Half of the attached explants had 
zero to twenty cells. The few cells leaving the explant were rounded up, blebby, and 
tended to be in clusters. Data describing the proportions of migrating cells are 
summarized in Table 1 and Figure 4. Typical appearances of the cultures are shown by 
photomicrographs in Figures 9a, 10a, and 1 la. 
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Table 1 The effects of VP A on explant attachment rates and cell emigration rates after 24 
hours in culture * 
Explant Percent of Mean Number Percent of 
Attachment Explants With of Emigrated Emigrated Cells 
Rate After 24 Emigrated Cells Cells per Incorporated 
Hours After 24 Hours Explant, Range Into Epithelial 
Sheet 
Control 95%+ 98%+ 275, 74-998 0-15% 
0.75 mM 90% 90%+ 218, 45-718 0-70% 
1.SmM 80% 80% 247, 24-920 0-100% 
2.0mM 75% 80% 133, 61-215 0-100% 
3.0mM 50% 40% 121**,0-321 0-25% 
*N = 20-45 explants per treatment level. 
**explants with less than 10 emigrated cells excluded (approximately one third of 
explants with emigrated cells apparent). 
Figure 4 The effects of VPA on explant attachment and cell emigration rates after 24 
hours in culture* 
100 
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**Explants with no cells incorporated into an epithelial sheet formation were seen in all 
treatment levels. 
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Figure 5a Control explant as seen with a phase contrast microscope, 40X. Cells are 
independent of one another as they leave the explant (A), center far left. The white arrow 
indicates a flattened cell displaying typical properties of a migrating cell, flattened 
against the culture surface with multiple filopodia extended. The black arrow indicates a 
rounded cell typical of a nonmigratory cell, possibly preparing for mitosis. 
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Figure 5b 2.0 mM VP A-treated explant as seen with a phase contrast microscope, 40X. 
The cells are not independent of one another when they leave the explant (A, lower right 
comer) but remain in an epithelial sheet (E). 
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The Effect ofVPA on Cell Morphometry and Cell Morphology 
To reveal the effect that VPA had on NCC morphology and motile behavior, 
explants were cultured in the presence of the drug and then 14 frame "movies" of the 
cells migrating on the culture surface were captured. Each dish was placed in an 
aluminum block stage warmer and once every three minutes for a total of39 minutes an 
image was captured of a section of the cell carpet surrounding the explant with individual 
flattened migratory cells (Figure 6a). Depending on the number of migrated cells in the 
microscopic field of view, 6-14 were selected to analyze. Each of these cells was hand 
traced with the computer mouse through the complete series of frames (Figure 6b ). The 
Optimas program was then commanded to generate a set of area morphometry data and a 
set of motion analysis data. These were exported to Microsoft Excel. There the 
appropriate parameters in the spreadsheet were selected for descriptive statistics, 
producing the mean, standard deviation, median, standard error, and range for each cell 
throughout the "movie." This data was then averaged for all cells and tested for 
significance with a Wilcoxon rank Sum test using the SAS statistical package (SAS 
Institute, Cary, NC) running on the university mainframe computer. 
Tables 2a-2d display the mean± standard deviation, median, and range for the 
morphometry parameters area, perimeter, circularity, elongation index, maximum length, 
maximum width, and statistical significance for each of the four drug treatments. Tables 
3a-3d display the mean ± standard deviation, median, and range of the motility 
parameters migration velocity, dynamic change in area and dynamic change in perimeter 
for each of the four drug treatments. For the majority of the parameters, both significant 
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increases and significant decreases were seen within the same drug treatment level. For 
example, as shown in Table 2a, in one experiment there was a significant difference 
between the mean control cell perimeter (170±1 l.7µm) and the mean 0.75 mM VPA-
treated cell perimeter (126±14.3µm) (p~0.0001). In another experiment comparison of 
the mean control cell perimeter (166±5.6µm) and the mean 0.75mM VPA-treated cell 
perimeter (209±1.8µm) was found to also be significantly different (p ~ 0.0001). 
Overall, area and maximum width were the most consistently decreased parameters for 
all drug-treated groups. Perimeter and maximum length were generally decreased for all 
drug-treated groups with the exception of the 2.0 mM treatment, which was generally 
increased. There was little consistency or significance in the differences between control 
and drug-treated cells for migration velocity, but dynamic change in area and perimeter 
were decreased overall, and all significant differences (p ~ 0.05) were decreases. 
For cells treated with 0.75mM VPA, migration velocity, dynamic change in area, 
and dynamic change in perimeter were consistently significantly lower than controls (p ~ 
0.05). For cells treated with 1.5 mM VPA, area, perimeter, maximum width, dynamic 
change in area, and dynamic change in perimeter showed consistently significantly lower 
levels than controls (p ~ 0.05). For cells treated with 2.0 mM VPA, significant increases 
in circularity were found (p ~ 0.05), while migration velocity, dynamic change in area, 
and dynamic change perimeter had significant differences from control that were 
consistently lower (p ~ 0.05). For cells treated with 3.0 mM VPA, area, dynamic change 
in area and dynamic change in perimeter were consistently significantly lower than 
controls(p ::::;; 0.05). Photographs of control and 2.0 mM VP A-treated cells are shown in 
Figures 6a-6b. 
Figure 6a Example of control cells ready for video image analysis with Optimas. 
Migrating cells are spread and irregular in shape, showing many characters of typical 
motile behavior. Magnification 200X. 
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Figure 6b Example of 2.0 mM VP A-treated cells just prior to video image analysis with 
Optimas. These migrating cells look similar to controls but are less spread on culture 
surface and have fewer processes. Arrow indicates a cell outlined for morphometry and 
motility data analysis with Optimas. Magnification 200X. 
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Table 2a The effect of0.75mM VPA on NCC morphometry parameters. Data from each 
experiment are given as mean ± standard deviation, and median with range as determined 
by video image analysis. 
Area Perimeter Circu- Elongation M. Length M. Width 
(um2) <um) larity Index (um) (um) 
Control 626±34.8 170±11.7 55±4.2 0.51±0.10 61±6.3 29±4.0 
629, 570-705 169, 153-191 54, 51-68 0.54, 0.38-0.63 59, 52-71 30, 23-33 
1369±44 264±11.2 49±6.0 0.46±0.02 90±2.9 38±1.3 
1368, 1293-1455 259, 250-290 47.3, 42-61 0.46, 0.44-0.48 89, 86-94 37, 35-39 
647±40.0 187±15.9 56±7.3 0.47±0.048 66±6.8 28±1.3 
633, 603-745 179, 170-218 54, 49-71 0.49, 0.40-0.54 63, 59-79 28, 24-29 
753±30.8 173±5.7 42±2.6 0.56±0.049 58±2.3 31±2.0 
749, 697-799 173, 165-183 43, 37-45 0.55, 0.50-0.66 57, 28-34 31, 28-34 
723±66.7 183±13.4 49±3.6 0.55±0.033 61±3.9 32±3.4 
733, 616-823 183, 159-202 50, 42-55 0.54, 0.49-0.61 62, 53-67 32, 28-37 
606±55.3 166±5.6 48±2.2 0.50±0.042 56±1.8 26±0.62 
598, 513-694 173, 120-189 50, 29-58 0.50, 0.44-0.57 56, 42-66 25, 22-30 
602±48.4 184±15.6 58±6.9 0.45±0.04 59±4.2 26±1.6 
619, 487-651 188, 150-200 59, 45-68 0.480.43-0.54 65, 60-70 28, 28-32 
0.75mM 613±69.0 126±14.3 28±4.5 0.68±0.03 43±4.7 27±2.1 
VPA 620, 483-702 123*, 101-150 26*, 22-35 0.67*, 0.61-0.75 40*, 35-50 27, 23-30 
516±20 124±4.2 31±1.7 0.69±0.05 40±2.0 26±1.7 
519*, 468-543 124*, 116-130 30*, 28-33 0.69*, 0.61-0.77 39*, 36-43 26*, 23-29 
784±51.7 203±15.1 54±6.1 0.48±0.04 67±2.2 30±2.4 
783*, 725-866 202*, 184-233 55, 45-64 0.48, 0.43-0.56 67*, 62-70 29*, 27-34 
583±34.7 142±6.4 36±3.9 0.49±0.016 53±2.4 25±1.1 
581 *, 545 -646 140*, 134-154 36*, 32-39 0.50, 0.46-0.51 52*, 48-56 24*, 22-25 
576±23.9 154±5.2 43±2.4 0.51±0.022 54±1.7 26±0.94 
584*, 523-610 156*, 143-162 43, 41-49 0.51*, 0.47-0.55 54*, 51-57 26*, 24-27 
762±26.6 182±5.0 45±2.1 0.50±0.296 62±2.5 30±1.4 
762, 171-802 181, 175-191 45*, 40-48 0.50*, 0.46-0.54 61, 58-68 29, 28-32 
889±42.1 209±1.8 62±5.4 0.50±0.02 65±0.58 31±0.29 
888*, 809-945 211 *, 200-220 55*, 46-85 0.50, 0.48-0.54 64*, 62-69 31 *, 29-32 
834±40.3 195±9.9 50±5.4 0.48±0.033 66±2.8 29±1.1 
843*, 738-886 197*, 175-210 50*, 38-56 0.48, 0.43-0.54 65*, 60-70 28*, 28-32 
*Significantly different from control, p :s; 0.05, Wilcoxon rank sum test 
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Table 2b The effect of 1.5 mM VPA on NCC morphometry parameters. Data from each 
experiment are given as mean± standard deviation, and median with range as determined 
by video image analysis. 
Area Perimeter Circu- Elongation M. Length M. Width 
<um2) <um) laritv Index <um) <um) 
Control 1129±43.9 226±7.3 48±3.7 0.47±0.078 80±3.7 35±4.3 
1122, 1078-1216 224, 215-236 49, 41-54 0.46, 0.33-0.60 81, 75-88 36, 28-41 
1072±41.5 244±7.8 58±4.4 0.45±0.031 83±2.7 34±2.3 
1069, 1013-1130 248, 231-254 58, 51-66 0.05, 0.39-0.50 83, 79-87 35, 30-38 
1169±28.2 253±9.1 56±4.5 0.47±0.023 83±1.9 37±1.3 
1176, 1125-1205 255, 238-266 57, 48-64 0.46, 0.42-0.50 83, 81-87 38, 35-39 
1221±40.0 225±8.4 46±3.9 0.48±0.024 82±3.5 35±1.1 
1236, 1151-1289 223, 214-243 44, 42-57 0.48, 0.43-0.52 81, 77-89 35, 33-37 
1021±43.7 314±9.4 104±5.6 0.36±0.070 111±4.7 35±5.0 
1020, 951-1097 314, 297-335 105,96-115 0.46, 0.41-0.52 112, 102-117 35, 29-43 
1209±45.0 265±7.3 60±4.2 0.51±0.055 79±3.5 40±2.8 
1208, 1115-1276 265, 251-280 60, 53-68 0.51, 0.44-0.62 78, 74-85 40, 35-45 
1.SmM 1038±110.0 213±15.9 48±3.1 0.45±0.020 75±4.5 33±2.0 
VPA 1051 *, 821-1172 217*, 178-237 47, 42-54 0.46*, 0.41-0.49 75, 66-82 33, 27-35 
867±26.7 202±7.5 49±4.1 0.58±0.019 64±2.2 36±0953 
865*, 818-917 203*, 187-215 50*, 40-56 0.57*, 0.55-0.62 64*, 60-67 36, 34-39 
1015±126 255±11.7 67±5.5 0.43±0.027 95±3.7 34±2.6 
1064*, 823-1150 256, 239-274 65*, 61-79 0.43*, 0.38-0.47 97*, 89-100 34*, 28-38 
976±61.9 234±13.8 59±3.7 0.40±0.028 88±2.5 30±3.3 
965*,892-1095 231, 216-256 59*, 52-67 0.38*, 0.35-0.44 88*, 84-93 29*, 26-37 
895±36.7 257±8.4 77±5.8 0.47±0.033 82±5.0 36±1.2 
889*,. 829-954 258*, 245-272 77*, 68-89 0.47*, 0.41-0.53 83*, 72-91 36, 33-37 
497±52.0 157±23.6 52±10.9 0.55±0.040 52±6.2 26±4.2 
486*, 406-594 157*, 119-200 54*, 32-72 0.54, 0.49-0.63 51 *, 42-61 25*, 20-36 
829±42.4 230±8.3 69±7.8 0.47±0.045 76±3.62 34±2.60 
848*, 765-888 229*, 211-246 68*, 55-87 0.47, 0.39-0.55 76, 72-84 35*, 29-38 
*Significantly different from control, p ::::;; 0.05, Wilcoxon rank sum test 
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Table 2c The effect of2.0 mM VPA on NCC morphometry parameters. Data from each 
experiment are given as mean ± standard deviation, and median with range as determined 
by video image analysis. 
Area Perimeter Circu- Elongation M. Length M. Width 
<um2) (um) larity Index (um) (um) 
Control 1250±39 241±7.4 47±2.4 0.46±0.032 83±2.0 36±2.4 
1253, 1177-1307 241, 233-259 48, 44-52 0.46, 0.40-0.51 83, 80-88 36, 33-41 
706±73.6 178±12.1 48±4.9 0.59±0.049 56±1.9 32±2.9 
720, 560-793 180, 156-193 47, 38-56 0.59, 0.50-0.65 56, 53-59 32, 28-36 
845±97.6 210±21 57±6.4 0.46±0.033 73±5.4 32±3.8 
863, 689-968 210, 171-247 58, 45-70 0.46, 0.41-0.51 73, 62-81 33, 24-36 
903±41.7 223±14.1 58±5.3 0.53±0.041 76±4.6 36±2.7 
911, 811-960 226, 198-245 57, 48-65 0.51, 0.48-0.62 76, 68-83 36,31-39 
2.0mM 661±33 172±7.6 47±3.6 0.45±0.024 64±3.6 25±0.99 
VPA 676*, 595-692 1 73 *, 15 6-182 49, 40-51 0.45, 0.40-0.48 64*, 57-69 26*, 23-27 
617±28 190±10.2 61±5.0 0.44±0.030 66±2.2 27±1.5 
623 *, 573-653 191 *, 171-202 62*, 52-66 0.45*, 0.37-0.49 66*, 60-69 27*, 24-29 
657±47.0 188±16.7 59±7.8 0.47±0.049 66±5.3 28±3.2 
652*, 581-736 186, 165-213 60*, 48-73 0.45*, 0.38-0.52 66*, 58-74 28*, 22-33 
560±47.7 181±12.2 62±6.2 0.52±0.650 58±3.6 27±3.5 
555*, 487-637 180*, 162-203 58, 55-74 0.53*, 0.44-0.68 58*, 51-64 27*, 22-33 
919±58.0 219±15.0 55±5.1 0.51±0.051 71±2.0 35±4.0 
901, 849-1033 213, 202-253 55, 49-67 0.50*, 0.44-0.60 71, 69-75 34, 30-42 
1394±48.4 271±12.7 56±4.6 0.48±0.027 90±4.7 40±1.7 
1411 *, 1286-1449 271 *, 238-292 56, 47-66 0.48*, 0.44-0.53 91 *, 76-94 40*, 37-43 
933±52.0 276±14.8 89±5.5 0.33±0.033 105±5.2 29±2.8 
943, 858-1006 283*, 245-293 89*, 77-97 0.33 *, 0.25-.040 106*, 95-113 29*, 25-33 
*Significantly different from control, p ~ 0.05, Wilcoxon rank sum test. 
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Table 2d The effect of3.0 mM VPA on NCC morphometry parameters. Data from each 
experiment are given as mean± standard deviation, and median with range as determined 
by video image analysis. 
Area Perimeter Circu- Elongation M. Length M. Width 
(um2) (11m) laritv Index (11m) (um) 
Control 906±26.3 212±11.6 55±5.8 0.48±0.027 77±4.7 31±1.7 
904, 863-945 211, 198-232 55, 47-64 0.49, 0.45-0.54 76, 71-83 31, 28-35 
1657±96.0 283±9.5 52±2.8 0.61±0.034 81±2.7 47±2.0 
1683, 1501-1767 282, 271-297 52, 48-57 0.61, 0.55-0.67 80, 78-86 48, 44-51 
1719±49.6 292±14.7 53±3.9 0.49±0.025 93±3.1 44±2.8 
1719, 1652-1844 290, 271-323 52, 47-59 0.50, 0.45-0.53 92, 89-98 43, 41-50 
1176±150.3 288±18.1 73±3.2 0.39±0.028 105±4.6 37±3.1 
1137, 998-1402 280, 268-317 74, 68-78 0.39, 0.35-0.44 103, 98-114 36, 33-42 
861±35.7 227±7.5 66±6.1 0.39±0.048 86±3.7 26±1.3 
867, 812-912 227, 218-243 67, 57-78 0.41, 0.31-0.45 85, 82-93 26, 24-28 
3.0mM 774±28.9 252±5.3 95±5.8 0.55±0.377 86±2.8 40±2.8 
VPA 768*, 742-819 249*, 246-263 93*,87-107 0.55*, 0.50-0.60 87*, 80-89 39*, 36-44 
954±75 224±13.0 55±3.7 0.53±0.04 73±6.1 37±2.7 
986*, 795-1046 228*, 196-243 56*, 48-61 0.53*, 0.46-0.60 74*, 61-80 38*, 33-43 
631±38.0 173±8.2 50±3.1 0.46±0.040 65±3.5 25±1.2 
617*, 581-698 176*, 162-187 49, 47-55 1.45*, 0.40-0.52 66*, 60-70 25*, 23-28 
913±95 191±19.9 43±5.8 0.53±0.027 66±5.8 31±2.6 
897*, 746-1040 198*, 155-214 44*, 33-49 0.52*, 0.49-0.59 69*, 55-71 32*, 27-35 
820±95.2 174±20.9 38±5.3 0.57±0.37 59±7.0 30±3.5 
808, 688-980 171 *, 145-203 39*, 30-47 0.57*, 0.52-0.65 56*, 51-68 31*,24-35 
*Significantly different from control, p ~ 0.05, Wilcoxon rank sum test. 
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Table 3a The effect of0.75mM VPA on NCC motility parameters. Data from each 
experiment are given as mean ± standard deviation, and median with range as determined 
by video image analysis. 
Dynamic Change in Dynamic Change in Migration Velocity 
Area Perimeter (µm per min2) 
(um 2) (um) 
Control 107±38.9 32±11.4 0.03±0.009 
97.3, 59.8-161.8 29, 17-52 0.03, 0.02-0.04 
217±146.9 36±16.7 0.03±0.011 
138, 84-549 32, 14-73 0.03, 0.01-0.05 
105±18.3 38±43.0 0.03±0.012 
105, 79-136 28, 16-172 0.02, 0.02-0.05 
83±20.1 18±4.2 0.03±0.007 
86, 49-124 18, 12-25 0.02, 0.02-0.04 
111±35.4 27±8.8 0.02±0.007 
113, 62-177 25, 15-47 0.02, 0.02-0.03 
165±60.6 39±3.6 0.04±0.012 
127, 85-275 36, 23-57 0.04, 0.02-0.07 
149±41.3 38±9.9 0.03±0.013 
136, 107-253 37, 25-58 0.03, 0.02-0.07 
0.75mMVPA 102±28.4 21±8.4 0.03±0.012 
96, 61-156 21*,9-38 0.03, 0.02-0.06 
104±39.5 22±8.6 0.03±0.010 
101 *, 50-184 20*, 13-40 0.03, 0.01-0.05 
125±48.9 32±10.9 0.04±0.021 
124, 57-241 34, 13-49 0.03, 0.02-0.09 
113±43.8 23±7.8 0.02±0.010 
104,64-184 24, 13-33 0.02, 0.01-0.04 
73±17.9 20±5.1 0.02±0.009 
70,43-109 20, 12-28 0.02, 0.02-0.05 
112±23.7 23±7.3 0.02±0.008 
114, 68-143 26, 10-30 0.02, 0.01-0.04 
209±103 27±10.3 0.02±0.010 
159, 73-371 24*, 16-54 0.02*, 0.01-0.03 
150±55.3 26±7.6 0.02±0.013 
138, 65-265 30*, 15-37 0.02*, 0.01-0.06 
*Significantly different from control, p::;; 0.05, Wilcoxon rank sum test. 
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Table 3b The effect of 1.5 mM VPA on NCC motility parameters. Data from each 
experiment are given as mean ± standard deviation, and median with range as determined 
by video image analysis. 
Dynamic Change in Dynamic Change in Migration Velocity 
Area Perimeter (µm per min2) 
(um 2) (um) 
Control 290±130 38±11.9 0.03±0.009 
317, 102-497 38, 22-61 0.02, 0.01-0.04 
180±99.3 40±20.4 0.3±0.011 
134, 52-368 31, 21.5-79 0.03, 0.01-0.05 
124±42.9 28±7.8 0.02±0.010 
114, 76-200 28, 19-44 0.02, 0.01-0.05 
269±134.3 30±9.8 0.02±0.006 
322, 115-502 29, 20-56 0.02, 0.01-0.04 
125±69 30±8.4 0.03±0.015 
99, 59-284 31, 18-46 0.02, 0.01-0.05 
188±88.8 45±16.7 0.02±0.008 
211, 57-371 45, 23-76 0.02, 0.01-0.04 
1.5mMVPA 137±48.0 25±8.8 0.02±0.006 
120*, 74-248 24*, 16-41 0.02, 0.01-0.03 
155±80 31±13.8 0.02±0.011 
154, 45-267 26, 17-54 0.03, 0.01-0.04 
124±52.4 27±8.1 0.02±0.011 
133, 50-222 27, 15-44 0.02, 0.01-0.04 
196±91 37±12.9 0.02±0.008 
183, 71-374 38, 21-54 0.02, 0.02-0.04 
130±47.6 34±13.7 0.04±0.012 
112, 70-226 34, 14-58 0.03, 0.02-0.06 
129±31.6 44±12.3 0.05±0.01 
123,84-198 45, 25-64 0.05*, 0.03-0.07 
126±48.8 23±7.6 0.02±0.007 
129, 65-245 22*, 13-37 0.02, 0.02-0.04 
*Significantly different from control, p ::; 0.05, Wilcoxon rank sum test. 
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Table 3c The effect of2.0 mM VPA on NCC motility parameters. Data from each 
experiment are given as mean± standard deviation, and median with range as determined 
by video image analysis. 
Dynamic Change in Dynamic Change in Migration Velocity 
Area Perimeter (µm per min2) 
(um 2) (um) 
Control 189±76.4 36±17.9 0.02±0.009 
194, 79-316 39, 19-53 0.02, 0.01-0.04 
142±52.8 29±5.7 0.03±0.011 
133, 54-230 28, 17-40 0.03, 0.01-0.05 
266±116.2 46±14.9 0.04±0.016 
247, 138-498 46, 20-76 0.05, 0.01-0.07 
214±68 47±16.7 0.04±0.012 
196, 121-329 45, 25-77 0.04, 0.02-0.07 
2.0mMVPA 169±66 49±41.3 0.03±0.01 
129*, 54-87 35, 26-176 0.03, 0.02-0.06 
122±72.0 40±22.3 0.03±0.016 
95, 57-294 31, 20-108 0.03, 0.02-0.07 
142±86 33±16.0 0.02±0.013 
105, 73-351 35, 10-58 0.02, 0.01-0.06 
115±39.1 34±9.3 0.03±0.136 
116*, 51-192 32*, 17-48 0.03, 0.01-0.06 
167±92.5 30±12.9 0.03±0.008 
141 *, 46-332 25*, 15-54 0.03*, 0.02-0.04 
266±147.2 41±18.2 0.02±0.010 
235, 108-634 38, 18-78 0.02, 0.01-0.05 
111±35.1 25±12.4 0.04±0.016 
111 *, 63-165 23*, 11-54 0.04, 0.02-0.07 
*Significantly different from control, p :s; 0.05, Wilcoxon rank sum test. 
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Table 3d The effect of3.0 mM VPA on NCC motility parameters. Data from each 
experiment are given as mean± standard deviation, and median with range as determined 
by video image analysis. 
Dynamic Change in Dynamic Change in Migration Velocity 
Area Perimeter (µm per min2) 
(um 2) (um) 
Control 139±48.5 31±9.8 0.03±0.008 
151, 64-222 30, 19-49 0.03, 0.01-0.04 
239±128.8 38±15.6 0.02±0.009 
201, 97-436 38, 16-60 0.02, 0.01-0.04 
364±219.0 48±24.4 0.02±0.006 
313, 90-768 50, 12-93 0.02, 0.01-0.03 
101±41 30±19.0 0.03±0.012 
91, 55-197 27, 7-69 0.02, 0.01-0.05 
100±70.4 25±13.6 0.03±0.132 
77, 26-301 22, 12-54 0.02, 0.01-0.05 
3.0mMVPA 86±33 35±41 0.03±0.014 
80*, 50-145 23, 13-136 0.03, 0.01-0.05 
100±22.7 24±6.0 0.03±0.007 
97*, 63-155 26*, 16-34 0.03, 0.02-0.05 
73±20.8 19±9.4 0.02±0.009 
67*,37-107 13*, 10-39 0.02, 0.01-0.04 
90±30.9 20±8.4 0.03±0.009 
77, 46-147 19, 11-36 0.03, 0.02-0.05 
92±40 17±7.5 0.02±0.012 
85, 37-169 15, 9.6-35 0.01, 0.01-0.04 
*Significantly different from control, p ~ 0.05, Wilcoxon rank sum test. 
79 
In order to more clearly display the effects of VP A on the NC Cs' morphometry 
and motility behaviors, the mean percent change ± standard error from control was 
calculated using the medians for each experiment. These values were then plotted in two 
bar graphs, one for cell morphometry (Figure 7) and one for cell motility parameters 
(Figure 8). Area overall was decreased for all groups from 6 to 29% of the control area. 
The effect ofVPA appeared to be dose responsive, although the data at 2.0 mM does not 
fit. Perimeter was also decreased to 13-19% of control level with the exception of2.0 
mM VP A, which had a mean increase of 2%. Maximum length data looked very similar 
to that of perimeter, with a decrease of 10-18% of controls for all treatments except 2.0 
mM, with an increase of 7% over controls. Maximum width was most affected at 1.5 
mM and 2.0 mM, an 11% decrease from controls. At 0.75 and 3.0 mM VPA, similar 
decreases of 6% and 7% from control respectively, were seen. Consistent with the length 
and width data, the elongation index was 4%-12% higher (cells less elongated) than 
controls for all treatments except 2.0 mM, which was 10% lower ( cells more elongated) 
than controls. 
Migration velocity was not consistently changed from controls, and showed a 
large amount of standard error. For 3.0 mM VPA, the mean was an 8% increase from 
controls, but the standard error was 19 .6%. Dynamic change in area seemed to 
demonstrate a dose response curve, with 0.75mM, 1.5mM, 2.0mM, and 3.0mM all 
showing decreases (4%, 20%, 29% and 28% respectively) compared to controls. 
Dynamic change in perimeter also indicated a possible dose response curve, with 
0.75mM, 1.5mM, 2.0mM, and 3.0mM all showing decreases of 14%, 10%, 16%, and 
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37% respectively. Taken as a whole, the data suggests that VPA-treated cells are smaller 
or less spread, and much less actively changing their shape than control cells. The effect 
ofVPA was usually stronger as its concentration was increased. This data suggests that 
these cells are less actively migrating since they are more rounded and not producing as 
many filopodia or cellular extensions, but the migration velocity data is not fully 
consistent with this finding. 
Figure 7. Mean percent increase or decrease from control in median* value for morphometry parameters 
± standard error . 
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Figure 8. Mean percent increase or decrease from control in median* value for 
motility parameters± standard error. 
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The Effect of VP A on Cell Proliferation 
As a measure of cell viability and proliferative status, the relative BrdU 
incorporation rates of control and the four VP A-treated groups were assessed (Table 4). 
After 24 hours in culture, appropriate BrdU containing media was exchanged for the 
original media followed by a two-hour incubation. During this time, mitotic cells would 
incorporate the BrdU in place ofthymidine during the process of DNA replication. By 
detecting the proportion of BrdU positive cells with a commercially available kit, the 
relative proliferative rate of the populations could be determined and statistically 
compared using a Student's T-test. A total of 512 of 1923 cells from nine control 
explants had positively stained nuclei. The mean percent per explant with positive nuclei 
was 25.9 (range, 8.1-42.1). A total of757 of 1960 cells from nine explants cultured in 
0. 75 mM VPA were BrdU positive. The mean percent per explant with positively stained 
nuclei was 35.1 (range, 17.9-55.6). The difference between this group and control was 
not statistically significant. A total of 1008 of 1978 cells from eight explants were 
positive for BrdU in those treated with 1.5 mM VP A, where the mean percent per explant 
with positively stained nuclei was 32.1 (range, 0.0-66.7). No statistically significant 
difference was found between this group and controls. A total of 153 of934 2.0 mM 
VP A exposed cells from eight explants were BrdU positive, where the mean percent per 
explant with positively stained nuclei was 14.7 (range, 6.4-30.7). This difference from 
the control group was statistically significant (P ~ 0.05). Finally, from eight explants 
cultured in 3.0 mM VPA, 0 of939 cells were positive for BrdU. This was a statistically 
significant reduction from the control (p ~ 0.001). 
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Table 4. Proliferation assay results of BrdU incorporation into nucleit of dividing NCCs 
in culture. 
V ALPROIC ACID 
CONCENTRATION 
0.00 mM 
0.75 mM 
1.50 mM 
2.00 mM 
3.00 mM 
TOTAL NUMBER 
OF EMIGRATED 
CELLS 
1923 
1960 
1978 
934 
939 
MEAN PERCENT 
OF EMIGRATED 
CELLS STAINED 
25.9 
35.1 
32.1 
14.7* 
0.0** 
t For 2 hours following 24 hour culture of explants from stage 10 embryos; n = 8-9 
explants in each group. 
* Significantly different from control, p < 0.05 
** Significantly different from control, p < 0.001 
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The Effect ofVPA on N-Cadherin (A-CAM) Expression 
Monoclonal Anti-A-Cell Adhesion Molecule (A-CAM) antibody (Sigma, St. 
Louis, MO) was used to visualize A-CAM at cell junctions in explants in control and all 
VP A concentrations after 24 hours in culture. The primary antibody was visualized with 
CY-3-conjugated streptavidin and images of the explants were captured with both 
fluorescence and phase-contrast optics. 
In control and all VPA-treated explants (Figures 9b-1 lb) there were high amounts 
of fluorescence within the attached explant, indicating high A-CAM expression in 
adherens junctions among cells still in contact within the original tissue. The 
fluorescence was evenly distributed throughout the complex multilayered network within 
the explant. In all cases the explant was several times brighter than the surrounding 
positive areas. In all treatments, independent migratory cells not in contact with any 
other cells did not exhibit any fluorescence (Figures 9b-1 lb). This implies that A-CAM 
was no longer present at the surface of these cells. In control (no VPA) dishes, cells in 
clusters did not exhibit any fluorescence. There were no epithelial sheets seen in any of 
the control dishes. 
In some of the 0.75 mM VPA-treated dishes (Figure 9a), epithelial sheets were 
present and had low amounts of discontinuous fluorescence in what appeared to be areas 
of cell-cell contact close to the explants (Figure 9b ), indicating the presence of A-CAM. 
The other cells in contact in the sheet did not indicate any A-CAM expression with 
fluorescence, despite appearing to be in full contact with one another. 
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In some 1.5 mM VPA-treated dishes containing cells in an epithelial arrangement, 
differentiation between explant and the epithelial sheet was not easily determined using 
phase contrast optics (Figure 10a). The A-CAM staining (Figure 10b) facilitated 
identification of the structures. There was high fluorescence in the area of the original 
explant, with a decreasing gradient of fluorescence in the attached epithelial sheet. The 
areas of staining are clearly at the boundaries of cellular contact within the sheet 
indicating the presence of A-CAM in adherens junctions. 
In the 2.0 mM VPA-treated dishes (Figure 1 la), explant morphology was similar 
to that seen in 1.5 mM. The level of A-CAM staining, however, was constant from the 
explant to the edge of the sheet at the cell junctions (Figure 11 b ). There also appeared to 
be additional diffuse staining in addition to the junctions. Possibly, there were two layers 
of cells in the sheet, and the lower levels of staining seen are from the junctions in the 
second layer, below the first. 
In. 3.0 mM treated dishes, there was high staining in attached explants, but no 
emigrated cells in sheets or individually were present. Therefore, no immunostaining of 
emigrated cells could be assessed. 
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Figure 9a Phase contrast image of explant cultured in 0. 75 mM VPA. The explant (A) is 
attached to the culture surface and cells are emigrating outward while maintaining contact 
with one another in an epithelial sheet (E) or individually (arrow). Magnification IOOX 
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Figure 9b Explant cultured in 0.75 mM VPA, primary antibody to A-CAM detected with 
a Cy-3 fluorescent label. In the multilayered explant (A), high amounts of A-CAM 
immunostaining are seen at the cell junctions. Very low levels of scattered staining are 
observed in part of the epithelial sheet flanking the explant (arrow). The antigen is no 
longer expressed in the rest of the sheet or on individual cells. Magnification 1 00X 
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Figure 1 Oa Phase contrast image of explant cultured in 1.5 mM VPA. The explant (A), 
is attached to the culture surface and cells are emigrating outward while maintaining 
contact with one another in an epithelial sheet (E), or individually (arrow). Magnification 
IOOX 
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Figure 1 Ob Explant cultured in 1.5 mM VP A, immunostained with primary antibody to 
A-CAM and detected with a Cy-3 fluorescent label. In the multilayered explant (A), high 
amounts of A-CAM staining are seen at the cell junctions. In the epithelial sheet (E), 
expression is seen at the regions of cell junctions and appears to decrease gradually as the 
distance from the explant increases. Staining is no longer observed in individual cells 
( arrow). Magnification 1 OOX 
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Figure 1 la Phase contrast image of explant cultured in 2.0 mM VPA. The explant (A), 
is attached to the culture surface and cells are emigrating outward while maintaining 
contact with one another in an epithelial sheet (E), or individually (arrow). Magnification 
lOOX 
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Figure 11 b Explant cultured in 2.0 mM VPA, immunostained with primary antibody to 
A-CAM and detected with a Cy-3 fluorescent label. In the multilayered explant (A), high 
amounts of A-CAM staining are seen at the cell junctions. In the epithelial sheet (E), 
staining is seen in the regions of cell junctions and does not appear to be down regulated 
as the distance from the explant increases as seen in 1.5 mM explants. Staining is no 
longer observed in individual cells (arrow). Magnification IOOX 
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The Effect ofVPA on Stress Fiber Distribution 
Fluorescein isothiocyanate (FITC)-labeled phalloidin, which binds and stabilizes 
filamentous actin (F-actin), was used to reveal the F-actin in NCC cultures. In control 
cultures (Figure 12), immunostained F-actin was concentrated in organized, 
multidirectional stress fibers and cortical areas of individual cultured NCCs. Staining in 
these areas was most intense in control cultures. In contrast, staining appeared to 
decrease in a manner that was somewhat dose-dependent in VP A-containing cultures. 
This suggests F-actin is decreased in the presence ofVPA, possibly dose dependantly. 
At the VPA concentration of 0.75 mM, the stress fibers appeared finer, and 
stained less intensely. Cortical area staining appeared as thick as in control cells, but also 
became less intense as VP A concentration increased. The distribution of staining was 
similar to that of controls. There was no detectable difference in appearance between 
0.75 mM (Figure 13) and 1.5 mM (Figure 15) VPA-treated cells with regard to stress 
fiber distribution and orientation or cortical actin staining in individual, spread NCCs. 
In 2.0 mM VP A-treated dishes (Figure 18), the stress fibers and cortical areas 
were predictably less intensely stained, however in a small proportion of spread cells 
there was an irregular, globular distribution of intense (bright) staining. This pattern was 
also seen in many rounded cells. This suggests a high amount of small actin filament 
fragments collecting in these cells. It is unlikely that this is an accumulation of globular 
actin, because phalloidin possesses a high affinity to filamentous, not globular, actin. 
In 3.0 mM VPA-treated dishes (Figure 19), there were few cells migrating 
outwardly, but those that were appeared to have a generally homogeneous pattern of 
fluorescence, only slightly brighter in nuclear and cortical areas. There were no 
prominent stress fibers. 
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Epithelial sheet morphology was seen in control, 0.75, and 1.5 mM VPA 
treatment conditions (Figures 14, 16, and 17). In control (not pictured) and 1.5 mM VP A 
treatment, where the explant had usual morphology, (explant edge easily distinguished 
from the pavement of cells), stress fibers within cells were multidirectional, numerous, 
and also appeared to continue from cell to cell. There were however some sheets that 
continued from explants that had lost their integrity, where the edge of the explant and 
sheet were not distinguishable. In these cases, the F-actin staining was markedly 
different in distribution. It appeared that only cortical areas of the cells were stained. 
The overall appearance was similar to the A-CAM staining of the same types of 
explant/sheet morphology. 
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Figure 12 NCCs cultured in control medium, immunostained with FITC-conjugated 
phalloidin. Staining was seen concentrated in the cortical areas of spread lamellapodia 
(black arrow). Staining was also seen in stress fibers, which radiate in several directions 
in spread cells and appear to be thick in diameter (white arrow). Epithelial sheet 
formation seen (E) with mass of stress fibers appearing to extend from cell to cell. 
Magnification 200X 
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Figure 13 NCCs cultured in 0.75 rnM VPA, irnrnunostained with FITC-conjugated 
phalloidin. Staining was seen concentrated in the cortical areas of spread larnellapodia 
(white arrow) similar to that seen in control cells. Staining was also seen in stress fibers, 
which appear to be less pronounced than in control cells (black arrow). Magnification 
200X 
Figure 14 Explant cultured in 0.75 mM VPA, immunostained with FITC-conjugated 
phalloidin. Sheet formation seen in a single culture. Staining appears to be at cell-cell 
borders (black arrow). Magnification 1 00X 
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Figure 15 NCCs cultured in 1.5 mM VPA, immunostained with FITC-conjugated 
phalloidin. Staining was seen in the cortical areas of spread lamellapodia (black arrow) 
but appeared to be less intense than in controls. Staining was also seen in stress fibers, 
which radiate in several directions in spread cells (white arrow). Magnification 200X 
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Figure 16 NCCs cultured in 1.5 mM VPA, immunostained with FITC-conjugated 
phalloidin. Epithelial sheet formation seen (E) with mass of stress fibers appearing to 
extend from cell to cell as in control. Note explant (A) edge is easily distinguished (black 
arrows). Magnification 1 00X 
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Figure 17 NCCs cultured in 1.5 mM VPA, immunostained with FITC-conjugated 
phalloidin. Epithelial sheet formation seen (E) with staining localized only to cortical 
areas of cells. Note that the explant (A) edge is not easily distinguished, having the rolled 
out appearance seen in multiple cultures. Individual cells (black arrow) are positive for 
actin, but stress fibers are not apparent. Magnification 1 00X 
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Figure 18 NCCs cultured in 2.0 mM VPA, immunostained with FITC-conjugated 
phalloidin. Staining was seen in the cortical areas and in stress fibers of spread cells (A 
and B, black arrows) but appeared to be less intense than in controls. Some individual 
cells appearing that had diffuse, clumped staining in all or part of the cell body (A and B, 
white arrows). In B, a group of cells independent of the explant (G) is seen displaying 
unusual actin distribution. Magnification 200X 
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Figure 19 NCCs cultured in 3.0 mM VPA, immunostained with FITC-conjugated 
phalloidin. Staining was seen concentrated in some cortical areas of cellular extensions 
as in lower drug concentrations and control (white arrow). Overall, staining is evenly 
distributed throughout the cell, prominant stress fibers are not seen (black arrow). 
Magnification 200X 
CHAPTER4 
DISCUSSION 
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Neural crest cells are a distinct group of multipotent cells first recognizable as 
they emerge from the neural tube as the neural folds rise up and fuse. These cells 
actively migrate outward over long distances using various extracellular guidance cues 
encountered in their varying environments. They cease migration in a variety of 
embryonic locations where they terminally differentiate into cartilage, bone, endocrine, 
connective, neural and pigment cell types (Erickson and Perris 1993; Bronner-Fraser 
1993). 
Valproic acid is a simple eight carbon branched chain fatty acid originally 
approved by the FDA in 1978 for the treatment of absence seizures (Lammer and others 
1987). Its usefulness has now been demonstrated in a wide variety of neurological 
disorders including schizophrenia, bi-polar disorder, and migraine prophylaxis (Citrome 
and others 2000; Mitchell 2000). Weak teratogenicity in laboratory species was 
established by Whittle in 1976, and the first data supporting a causal relationship between 
VP A and NTDs became known in 1982 from Robert and Guibaud. A series of anomalies 
termed fetal valproate syndrome was described by Clayton-Smith and Donnai in 1995. 
These included neural tube defects (spina bifida), and congenital heart defects. Spina 
bifida, the most commonly noted birth defect, was calculated to be 1-2% more frequent in 
embryos exposed to valproate than not. Spina bifida has a variety of origins, and the 
overall mechanism of this defect is not clearly understood. Failure of the neural folds to 
completely fuse along any portion of the neural tube can result in this NTD. Altered 
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levels of extracellular matrix molecules, cell adhesion molecules, and cell proliferation 
have been found to contribute to the incidence ofNTDs (Newgreen and others 1997; 
Bennett and others 2000). 
The Effect of VP A on Explant Attachment 
In this study, VPA affected the ability of explanted neural fold tissues to attach to 
the culture surface in a dose-dependant manner. As the concentration of drug increased, 
consistently lower percentages of explants were able to adhere to the substratum. In 
addition, 3.0 mM VPA highly impaired the ability of the NCCs to migrate outward as 
very few explants overall had more than 100 cells visible, whereas in controls and at 
lower concentrations, the mean numbers of emigrated cells were over 200. 
The Effect of VPA on NCC Morphology in Culture 
Valproic acid has been shown to increase mean cell area offibroblastoid mouse 
L-cells (Berezin and others 1996). In this study, however, the mean cell area of migrated 
cells was not consistently increased or decreased. Significant increases and decreases 
were seen in separate experiments within the same drug concentration. Generally, more 
decreases in area values were noted than increases within each VP A treatment level. 
With 1.5 and 3.0 mM VPA exposure, the mean percent changes in median area values 
from control were 20-30% lower overall, and with 2.0 mM VPA exposure median area 
value was lowered about 6%. However, the effect ofVPA on migrated cell area lacked 
consistency. 
In general, when compared to controls, the 0.75, 1.5 and 3.0 mM treated cells 
appeared more rounded with lower length and width measurements and higher elongation 
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index values, but there were no clear trends. The lower area values and more rounded 
appearance of the NCCs supports previous observations of cells that are less migratory, 
such as those in preparation for division. It is known that migrating cells, in preparation 
for mitosis, become less spread out in shape and decrease the number of substratum 
contacts, giving them a more rounded appearance. 
The Effect ofVPA on NCC Motility on Culture 
It might be expected, based on the overall morphology of NC Cs cultured in VP A, 
that migration rates would be lower for VP A exposed cells. Dose-dependant decreases in 
the migration speed of L929 cells, together with an increase in persistence of direction 
have been seen in the presence ofVPA (Walmod and others 1998). In the present study 
with chick NCCs, migration velocity was highly variable with large amounts of standard 
error within experimental groups. Both significant increases and decreases in migration 
rate were seen within experiments at all drug levels when compared to controls. Overall, 
there were no clear effects ofVPA exposure seen on migration rates of these cells. The 
dynamic activity of the cell calculated by determining changes in area and perimeter over 
time, however, did appear to be consistently lowered as VP A concentration increased. 
These cell's lamellapodia may not be as active. Possibly, this is a result of internal 
cytoskeletal changes in the actin network responsible for membrane protrusion and 
retraction. 
VPA concentrations of 3 mM have previously been found to change cytoskeletal 
organization and increase the presence of focal adhesions (W almod and others 1998). In 
addition, microspikes were found to be missing in VPA-treated cells (Walmod and others 
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1998). In our study, median perimeter values were lower for the 0.75, 1.5 and 3.0 mM 
treated groups, suggesting a lower number of membrane protrusions. 
The Effect ofVPA on the Actin Cytoskeleton 
Confocal micrographs of fluorescence staining of microtubules, F-actin, and 
selected focal adhesion proteins compiled by Walmod and others (1998) demonstrated 
that VPA-exposure caused enhanced focal adhesion formation. This was accompanied 
by a rearrangement of F-actin reflected in an increase in stress fiber formation in L929 
cells. A decrease was seen in the amount of cortical F-actin. Stress fibers in VP A-treated 
cells were found in a predominantly perinuclear organization rather than in a cortical 
mesh as in control cells, and the relative amount ofF-actin per cell was significantly 
higher (23%) for treated cells (Walmod and others 1998). In our study, F-actin was 
immunolocalized to stress fibers and cortical areas of individual cultured NCCs. Staining 
in these areas was most intense in control cultures. As VP A concentration increased, the 
stress fibers appeared more fine and stained less intensely. Cortical areas appeared to 
have the same amount of intensity relative to the stress fibers for control through 2.0 mM 
VPA. There was no difference in appearance between 0.75 mM and 1.5 mM VPA-
treated cells with regard to stress fibers or cortical actin staining in individual spread 
NCCs. 
In 2.0 mM VPA-treated dishes, the inverse correlation between VPA 
concentration and F-actin staining in stress fibers and cortical areas was still apparent. 
However, in a small proportion of spread cells there was an irregular, globular 
distribution of staining. This was also seen in many rounded cells. This suggests a high 
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amount of small actin filament fragments collecting in these cells. It is unlikely that this 
is an accumulation of globular actin, because phalloidin possesses a high affinity to 
filamentous, not globular actin. Walmod and others (1998) showed that after VPA 
treatment, the distribution of gelsolin was altered. They reported that it was found in a 
diffuse perinuclear pattern (where stress fibers were) unlike the pattern in control cells 
where it was found in the peripheral membrane ruffles. VP A also altered gelsolin so that 
it responded insignificantly to the addition of the PIPi-binding gelsolin-peptide. This is 
interesting because gelsolin is a compact actin binding protein found in many vertebrate 
cells which blocks lengthening of actin filaments, and can also sever them by breaking 
bonds between actin monomers. An alteration of gelsolin production or distribution by 
VPA in NCCs may account for the disturbed F-actin destitution seen in the 2.0 mM VPA 
cultures. Further investigation including staining for gelsolin could help clarify this 
mystery. 
In 3.0 mM VPA-treated dishes, there were few cells migrating outwardly. Those 
that were appeared to have a low amount ofF-actin fluorescence, slightly increased in 
cortical areas unlike controls, which had very bright staining in both stress fibers and 
cortical areas. There were no prominent stress fibers seen in the 3.0 mM-treated cultures. 
This is unlike results seen with the L929 cells exposed to 3 .0 mM VP A. It is yet to be 
determined what causes these two different results in these differing cell types. Differing 
mechanisms of action, or roles that VP A may play in normal cell function could be 
explored. It would be interesting to immunolocalize G-actin in migrating NCCs exposed 
to 3.0 mM VPA to investigate whether actin was being prohibited from filament 
formation. 
The Effect ofVPA on Epithelial Sheet Morphology 
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Epithelial sheet morphology was seen in neural fold explants cultured in control, 
0.75, and 1.5 mM VPA treatment conditions. In control and 1.5 mM VPA, the explant 
had usual morphology, with the explant edge easily distinguished from the pavement of 
cells. Stress fibers within the cells were multidirectional, numerous, and also appeared to 
continue between multiple cells. There were however some sheets that continued from 
explants that had lost their integrity, where the edge of the explant and sheet were not 
distinguishable. In these cases, the F-actin staining was markedly different in 
distribution. It appeared that only cortical areas of cells were stained, and not stress 
fibers. This appears to be the first observations of this phenomenon. 
The Effect ofVPA on Cell-Substratum and Cell-Cell Contacts 
Walmod and others (1998) showed that VPA increased the presence of focal 
adhesions indicated by a higher proportion of paxillin, vinculin, and F AK staining in 
treated than in control cells. We did not investigate the presence of focal adhesion 
proteins, however based on the smaller areas and generalized cell rounding seen in our 
VP A-treated cultures; it seems probable that their presence would be reduced overall. 
In mice with abnormally high levels of the cell adhesion molecule N-CAM, NCCs 
fail to migrate from segments of the neural tube, and resulting embryos display spina 
bifida (Moase and Trasler 1990, 1991). In human neuroblastoma cells, N-CAM 
expression is upregulated in the presence ofVPA (Cinatle Jr. and others 1996). In avian 
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neural crest cells, A-CAM is not present in migrating cells, but is seen in premigratory 
cells in culture (Delannet and Duband 1992). 
In this study, A-CAM (N-cadherin) was immunolocalized in the NCC cultures 
and visualized with a fluorescent label. Cells in all treatment levels independently 
migrating did not demonstrate A-CAM expression. Cells within the explant, and any 
cells appearing to be part of an epithelial sheet where it was continuous with the explant, 
did localize the antibody at the borders of the cells within the sheet. This staining pattern 
appeared to be most intense proximal to the explant, and decrease in intensity toward the 
edge of the sheet. The highest intensity levels were seen in the 2.0 mM VPA group (3.0 
mM was not tested because of the lack of emigrated cells). If cells appeared to be 
grouped but were not in contact with the explant, no A-CAM staining was seen. The Ras 
GTPase RhoB has been demonstrated to be expressed in the dorsal neural tube. It also is 
transiently expressed in migrating NCCs. When rho activity is blocked, they are 
prevented .in their delamination from the dorsal neural tube, suggesting a role for rhoB in 
this step. NCCs have a more elongated morphology overall when rho activity is blocked, 
but no significant changes were noted in migration (Liu and Jessell 1998). 
The receptors for factors that can induce epithelial-to-mesenchymal transition 
(EMT) are protein tyrosine kinases (PTKs) (Komada and Kitamura 1993). Tyrosine 
kinase inhibitors have been shown to elevate cadherin levels at cell adhesions and 
increase NCC-cell adhesion (Monier-Gavelle and Duband 1995). The presence of VP A 
in the embryonic system may modify regulation of expression or enzyme activity of 
particular protein tyrosine phosphatases (PTPases) and PTKs thereby altering 
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maintenance of cell-cell adhesion and dynamic substrate adhesion through these 
enzymes. When serine-threonine kinases, tyrosine kinases, and phosphotyrosine 
phosphatases are inhibited, aggregates of cells form with tight cell-cell cohesion among 
cells accompanied by A-CAM accumulation in the areas of intercellular contacts. This 
indicates that a complex cascade of intracellular signals involving kinases and 
phosphatases elicited by surface receptors may be the mechanism of A-CAM-mediated 
interactions. Agents that interfere with fibronectin-to-integrin surface interactions cause 
rapid A-CAM-mediated cell-cell aggregations. This process is mediated through 
incorporation of A-CAM molecules from cytoplasmic pools into adherensjunctions, 
which are associated with cytoskeletal elements (Monier-Gavelle and Duband 1997). 
VP A appears to effect the epithelial-mesenchymal transition necessary for NCCs to begin 
proper migration. Alteration of A-CAM expression or regulation may strengthen these 
cell junctions in a manner that is keeping the cells from releasing from one another. If 
neural crest cells are being prevented from leaving the neural tube, NTDs might result 
from an overcrowding of cells in localized areas. Other malformations may result from 
reduced numbers of NCC derivatives in their needed locations in the embryo. 
Induction of neural crest and neural tube defects is a general effect ofN-methyl-
D-aspartate (NMDA) receptor antagonists. Proteins involved in functional NMDA 
receptors are present as early as stage 10 in the chick. Evidence from later stages of 
development indicates the NMDA receptor is a regulator of neuronal cell migration, cell-
cell adhesion, and apoptosis (Komuro and Rakie 1993; Rashid and Cambray-Deakin 
1992; Balazs and others 1989). The NMDA receptor antagonists ethanol, homocysteine, 
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and VP A have been identified as possibly contributing to NTDs by competitive 
inhibition. In avian embryos, homocysteine induces neural tube, conotruncal, and 
orofacial malformations similar to those found in VP A exposed embryos. Ethanol is 
responsible for 'fetal alcohol syndrome', characterized by maxilo-facial, heart, and other 
systemic defects. Due to the similarity of deformations caused by these three antagonists, 
similar teratogenic mechanisms involving the NMDA receptor may be at work. When 
the balance of NMDA receptor agonists and antagonists is disrupted during development 
by the addition ofVPA or another antagonist, congenital defects of the neural crest and 
neural tube derivatives may result. 
The Effect of VP A on Cell Proliferation 
Another contributing factor for NTD development may be altered cell 
proliferation. A lowered rate of cell proliferation appears to be a mechanism of NTD 
pathogenesis in curly tail embryos (Copp 1988). One mM VPA has been shown to 
achieve 50% inhibition of C6 glioma cell proliferation in culture, with higher 
concentrations completely arresting the cell cycle (Martin and Regan 1997). Other 
agents found to inhibit this cell line have been associated with neural tube defects (Regan 
and others 1990). In the present study, 0.75 mM and 1.5 mM VPA actually increased the 
number of cells that incorporated BrdU 6-9%. NCC exposure to 2.0 mM VPA 
significantly lowered their proliferation rate by 12%. At 3.0 mM, no uptake of BrdU was 
detected, suggesting that this concentration arrested NCC DNA synthesis. Altering cell 
proliferation lowers the number of cells available to contribute to tissues within the 
embryo that are dependent on NCCs. 
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Summary 
In summary, alterations in the overall cell activity and cytoskeletal actin filament 
distribution or maintenance may mediate the teratogenicity ofVPA through alteration of 
neural crest cell migration in embryos exposed to it. Increased cell-cell adhesion, 
possibly through A-CAM and lowered or terminated cell proliferation through exposure 
to VP A might alter the integrity of the neural tube, allowing the development of NTDs 
such as spina bifida, and also contribute to other defects seen in VP A-exposed fetuses 
through the lowered levels ofNCCs able to contribute to derivatives of the neural crest. 
Altered cell proliferation rates are a result ofVPA exposure, and have been found to 
contribute to NTDs in a variety of animal models. VP A appears to have multiple effects 
on the developing embryo, interfering with multiple activities of embryonic cell biology. 
Further studies investigating the internal cytoskeletal effects of VP A on focal adhesion 
proteins and actin-binding proteins such as gelsolin, as well as rescuing experiments with 
folic acid or methionine, or competitive inhibitors of the NMDA receptor should be the 
next steps in discovering the teratogenic mechanisms of VP A. 
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